Thiamine deficiency …

Neeraj Kumar MD

General Neurology

Updated 05.08.2023
Released 10.30.2007
Expires For CME 05.08.2026

Thiamine deficiency

Author: Neeraj Kumar MD

See Contributor Disclosures

Editor: Douglas J Lanska MD MS MSPH

Thiamine deficiency

In This Article

Quick Link

Introduction

Overview

The best characterized human neurologic disorders related to thiamine deficiency are beriberi, Wernicke encephalopathy, and Korsakoff syndrome. Thiamine deficiency is increasingly being recognized in nonalcoholics. Some neurologic complications following bariatric surgery are related to thiamine deficiency. The classic Wernicke encephalopathy triad of ocular abnormalities, gait ataxia, and mental status changes is infrequently seen. Prompt recognition and adequate therapy are key factors in improving prognosis.

Key points

	• The best characterized human neurologic disorders related to thiamine deficiency are beriberi, Wernicke encephalopathy, and Korsakoff syndrome.
	• Thiamine deficiency is increasingly being recognized in non-alcoholics.
	• Thiamine deficiency should be considered as potential cause of neurologic deterioration in all critically ill patients.
	• Early neurologic complications following bariatric surgery are related to thiamine deficiency.
	• The classic Wernicke encephalopathy triad of ocular abnormalities, gait ataxia, and mental status changes is infrequently seen.
	• Prompt recognition and adequate therapy are key factors in improving prognosis.

Historical note and terminology

The best characterized human neurologic disorders related to thiamine deficiency are beriberi, Wernicke encephalopathy, and Korsakoff syndrome (also referred to as Korsakoff psychosis). Because of the close relationship between Wernicke encephalopathy and Korsakoff syndrome, the term Wernicke-Korsakoff syndrome is commonly used.

Beriberi has the distinction of being the first-identified human nutritional deficiency disorder. During the industrial revolution of the nineteenth century, introduction of milled rice was accompanied by epidemics of beriberi. Milling removes the husk, which is a rich source of thiamine; therefore, polished white rice is deficient in thiamine. A connection between the consumption of polished rice and beriberi was shown in the latter part of the nineteenth century. In the 1950s, universal thiamine enrichment of rice, grains, and flour products was undertaken. Wernicke encephalopathy was first described in 1881 by Carl Wernicke who described it as an acute superior hemorrhagic polioencephalitis (“polioencephalitis hemorrhagica superioris”) in two alcoholic men and a woman who developed recurrent vomiting due to pyloric stenosis related to sulphuric acid ingestion. In the 1940s it was established that Wernicke encephalopathy is caused by thiamine deficiency. The historical aspects of thiamine deficiency have been reviewed in detail in a publication (223).

Sources of thiamine. The highest concentrations of thiamine are found in yeast and in the pericarp of grain. Most cereals and breads are fortified with thiamine. Organ meats are a good source of thiamine; dairy products, seafood, and fruits are poor sources. Preterm breast milk is poorer in thiamine as compared to term breast milk (93). Cow’s milk and infant formula have a higher level of thiamine than human milk or evaporated milk formula (97). Prolonged cooking of food, baking of bread, and pasteurization of milk are all potential causes of thiamine loss. Thiamine does not occur in fats and oils.

Thiamine requirement. Thiamine requirement is related to the total caloric intake and proportion of calories provided as carbohydrates (239). A high caloric and high carbohydrate diet increases the demand for thiamine. According to the Food and Agriculture Organization and the World Health Organization, the recommended intake is 0.4 mg of thiamine per 1000 kcal; the Food and Nutrition Board recommends a daily allowance of 0.5 mg per 1000 kcals. The median intake of thiamine from food in the United States is approximately 2 mg/day. Thiamine requirement is also dependent on the body’s metabolic rate with the requirement being the greatest during periods of high metabolic demand. Thiamine requirements increase in children, during pregnancy and lactation, and with vigorous exercise. Increased requirements are also seen in hyperthyroidism, malignancy, systemic infections, and in the critically ill. In patients with a marginal nutritional status, the increased metabolic demand associated with these conditions can precipitate symptoms of thiamine deficiency.

Physiology. The terms vitamin B1 and thiamine are used interchangeably. At low concentrations, thiamine is absorbed in jejunum and ileum by an active, carrier-mediated, rate-limited process (282). At higher concentrations, absorption takes place by passive diffusion. Adequate blood thiamine levels can be rapidly achieved with high-dose oral thiamine (270). After gastrointestinal uptake, thiamine is transported by portal blood to the liver. Transport of thiamine across the blood-brain barrier occurs by both active and passive mechanisms (282; 167). Thiamine functions as a coenzyme in the metabolism of carbohydrates, lipids, and amino acids. It has a role in energy production by adenosine triphosphate synthesis, in myelin sheath maintenance, and in neurotransmitter production. Following cellular uptake, thiamine is phosphorylated into thiamine diphosphate, the metabolically active form that is involved in several enzyme systems (40; 180). Thiamine diphosphate is a cofactor for the pyruvate dehydrogenase complex, alpha-ketoglutarate dehydrogenase, and transketolase (40). Pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase are involved in the tricarboxylic acid cycle in oxidative decarboxylation of alpha-ketoacids such as pyruvate and alpha-ketoglutarate to acetyl CoA and succinate, respectively. Transketolase transfers activated aldehydes in the hexose monophosphate shunt (pentose-phosphate pathway) in the generation of nicotinamide adenine dinucleotide phosphate (NADPH) for reductive biosynthesis. Thiamine diphosphate may be further phosphorylated to thiamine triphosphate, which may activate high-conductance chloride channels and have a role in regulating cholinergic and serotonergic neurotransmission (23).

Clinical manifestations

Presentation and course

Thiamine deficiency affects the central nervous system, peripheral nervous system, and cardiovascular system (75; 244; 99; 155; 92; 228; 266; 144; 269). These may be involved in various combinations. The broad spectrum of clinical manifestations associated with thiamine deficiency has been referred to in the literature by the designation of thiamine deficiency disorders (269). Cardiac involvement may manifest as high-output or low-output cardiac failure. Neurologic involvement may manifest as beriberi, Wernicke encephalopathy, or Korsakoff syndrome, with or without an associated peripheral neuropathy. Wernicke encephalopathy often results from severe, short-term thiamine deficiency, whereas peripheral neuropathy is more often a consequence of prolonged mild to moderate thiamine deficiency (244). The symptoms and signs of thiamine deficiency depend on the clinical setting, patient’s age, and genetic susceptibility (244). It had also been suggested that the response to thiamine deficiency may be population-specific and may relate to transketolase deficiency (26). This has not been substantiated by subsequent studies (182). It has been suggested that Europeans develop a dry beriberi with polyneuropathy and Wernicke encephalopathy; Asians are more prone to developing a wet beriberi (26). The symptoms of subclinical thiamine deficiency are often vague and nonspecific and include fatigue, irritability, headaches, and lethargy (244).

Thiamine-responsive pyruvate dehydrogenase deficiency has been reported in an adult with peripheral neuropathy and optic neuropathy (247). Thiamine-responsive pyruvate dehydrogenase complex deficiency presenting with recurrent muscle weakness was described in context of a novel mutation in the PDHA1 gene (111). The following signs, often in combination, suggest pyruvate dehydrogenase complex deficiency: Leigh syndrome, fever-induced ataxia or weakness, polyneuropathy, and optic neuropathy. Thiamine responsive megaloblastic anemia syndrome is an uncommon autosomal recessive disorder due to mutations in SLC19A2, a thiamine transporter coding gene. It is characterized by diabetes mellitus and deafness in association with anemia. Cardiac conduction defects may be seen in some patients (18). Inadequate thiamine supplementation in these patients may precipitate ketoacidosis (156). Thiamine-responsive megaloblastic anemia should be considered in the differential diagnosis of diabetes presenting in the neonatal period (254). Mutations in SLC19A3 cause biotin–thiamine-responsive basal ganglia disease (12; 14; 07; 215; 178). Three forms are recognized: an infantile form, a classic childhood form, or adult Wernicke encephalopathy. Afflicted children present with encephalopathy, and MRI shows striatal signal abnormalities. SLC19A1 encodes the reduced folate carrier, a transporter for physiological folate in plasma; genetic variations in SLC19A1 gene may contribute to the development of Wernicke-Korsakoff syndrome through modulation of thiamine pyrophosphate transport in cell (207).

Beriberi and thiamine deficiency neuropathy. The three forms of beriberi are dry beriberi, wet beriberi, and infantile beriberi. Dry beriberi is characterized by a sensorimotor, distal, axonal peripheral neuropathy often associated with calf cramps, muscle tenderness, and burning feet (211). Autonomic neuropathy may be present. Classic descriptions of beriberi have also reported hoarseness, and tongue and facial weakness. Pedal edema may be seen due to coexisting wet beriberi. Wet beriberi is associated with a high output congestive heart failure with peripheral neuropathy. This distinction is of limited significance as the wet form may be converted to the dry form after diuresis. Wet beriberi may coexist with Wernicke encephalopathy (213). The terms “wet” and “dry” beriberi have been used to describe the presence or absence of edema in neuropathic beriberi. “Shoshin” beriberi is the name given to a fulminant form that presents with tachycardia and circulatory collapse. Acute quadriplegia due to central-pontine myelinolysis has been reported in Shoshin beriberi (03). Infantile beriberi bears little resemblance to the adult form. It is seen in infants breastfed by mothers with thiamine deficiency or in infants fed on thiamine deficient diets. Infantile beriberi is seen between 2 and 12 months of age and may present with the cardiac, aphonic, or pseudomeningitic forms. Clinical features include cardiomyopathy, vomiting, diarrhea, failure to thrive, irritability, nystagmus, ophthalmoplegia, and respiratory symptoms (86). Refractory epilepsy has also been reported as a consequence of infantile thiamine deficiency (85). A report suggests four4 forms of infantile thiamine deficiency: a form associated with lactic acidosis wherein a history of reflux is followed by irritability and acidotic breathing; a form that presents with pulmonary arterial hypertension and has hoarseness and irritability; a form that resembles classic Wernicke encephalopathy; and a mixed presentation (232). The term gastrointestinal beriberi has been used to describe a primary gastrointestinal thiamine deficiency syndrome characterized by abdominal pain, vomiting, and lactic acidosis (72).

Alcoholic neuropathy is distinct from thiamine deficiency-related neuropathy (149; 146; 186). Alcoholic neuropathy is a slowly progressive, painful, predominantly sensory neuropathy with preferential involvement of small-fiber function. In contrast, thiamine deficiency-related neuropathy is often a more rapidly progressive, sensorimotor neuropathy with large-fiber predominant sensory loss. Thiamine deficiency has been reported to present with subacute sensory ataxia and optic neuropathy (271). Alcohol abuse and malnutrition can cause a severe acute axonal polyneuropathy that may mimic Guillain-Barré syndrome (308). Thiamine deficiency-related neuropathy can also mimic Guillain-Barré syndrome (147; 198; 82; 140; 194). Subperineurial edema may be more prominent in thiamine deficiency-related neuropathy, whereas segmental demyelination and remyelination resulting from widening of consecutive nodes of Ranvier may be more frequent in alcoholic neuropathy.

Wernicke encephalopathy. Wernicke encephalopathy related to alcoholism is more common in men. Wernicke encephalopathy related to bariatric surgery is more commonly reported in women. The clinical features of Wernicke encephalopathy include a subacute onset of the classic triad of ocular abnormalities, gait ataxia, and mental status changes (109; 233; 110; 43; 244; 99; 155). The onset may be gradual, and the classic triad is frequently absent. In one series the complete triad was seen in only 10% (110). Ophthalmoplegia was seen in 29% of patients and ataxia in only 23%. About 16% to 19% of patients have none of the manifestations related to the classic triad (288; 109; 110). One or more components of the triad do generally appear later in the course (296). Reliance on the described triad of ophthalmoplegia, ataxia, and confusion and not recognizing thiamine deficiency in nonalcoholics may result in missing the diagnosis (233). Hyperemesis gravidarum may in particular be associated with atypical manifestations (69). The diagnosis should be considered even if only one component of the classic triad is present. The presence of nonspecific or poorly recognized signs and symptoms also result in missing the diagnosis. Skin changes, tongue redness, and other features of chronic liver disease may be present. Rarely, a Marchiafava-Bignami type presentation characterized by interhemispheric disconnection and imaging evidence of callosal involvement has been reported with thiamine deficiency (139; 318).

Ocular abnormalities include nystagmus (horizontal more common than vertical), ophthalmoparesis (commonly involving the lateral recti), and conjugate gaze palsies (usually horizontal) (206). Complete ophthalmoplegia is rare. Other reported findings include sluggish pupillary reactivity, anisocoria, miosis, light-near dissociation, optic neuropathy, central scotomas, and reduced visual acuity. Sudden bilateral blindness may occur and has been reported as a presenting manifestation (274). Retinal hemorrhages, papilledema, and macular edema have also been described (171; 224; 195; 175; 192; 296; 154; 58; 168; 49). A Miller Fisher syndrome-like presentation was noted in a patient with Wernicke encephalopathy (65).

The gait and trunk ataxia is a consequence of cerebellar and vestibular dysfunction. Vestibular dysfunction is an under-appreciated feature and may be demonstrable on caloric testing or with the head impulse maneuver (280; 100; 51). In some patients, the ataxia may be accompanied by dysarthria. A coexisting chronic peripheral neuropathy may be an additional contributing factor for the gait difficulty. Over 80% of patients may have an associated peripheral neuropathy. Also reported is an accompanying acute, rapidly progressive, peripheral neuropathy that may be misdiagnosed as Guillain-Barre syndrome (148; 125; 256). Proximal myopathy and fasciculations have been rarely reported along with the more classic manifestations of Wernicke encephalopathy (279). Mental status changes are the most constant component of the disease and include inability to concentrate, apathy, impaired awareness of the immediate situation, spatial disorientation, and confusion–including frank psychosis (233; 127; 310). Mental sluggishness and restless may be the earliest and rarely only manifestations (233). In some autopsy-confirmed cases of Wernicke encephalopathy, the only clinical manifestation was that of psychomotor retardation (42). If untreated, this can progress to stupor, coma, and death. Rarely, hypoactive delirium or coma may be the sole manifestation of Wernicke encephalopathy (301; 71; 135; 288; 292). It is important to recognize that the intoxicated patient who does not recover fully and spontaneously may be suffering from Wernicke encephalopathy (282). In terminally ill patients Wernicke encephalopathy may present as delirium (214).

Involvement of the hypothalamic and brainstem autonomic pathways may be associated with hypothermia, hypotension, or bradycardia (24; 142; 02; 166; 108; 71; 135). A hypothalamic syndrome characterized by hyponatremia, hypotension, anorexia, and apathy has been reported (320). Refractory hypotension has been reported as a presenting manifestation of Wernicke encephalopathy (302). The presence of hyperthermia usually indicates a complicating illness. The occurrence of hyperthermia of unknown cause has also been reported. Also reported is a patient with hyperthermia, chorea, and increased tone (246). Rarely, weakness, including dense quadriparesis, has been described (138; 91). Other unusual manifestations include seizures, myoclonus, catatonia, dysphagia, tinnitus, hearing loss, and micturition disturbance (291; 77; 39; 94; 265; 88; 132; 311; 04; 101). Dysphagia or acute bilateral deafness may rarely be the presenting manifestation (291; 132; 317; 59). Palinacousis in association with hearing loss has been reported (204). In an isolated report, orthostatic tremor was the presenting manifestation of thiamine deficiency (201).

Korsakoff syndrome. About 80% of patients with Wernicke encephalopathy who survive develop Korsakoff syndrome (57; 282). Korsakoff syndrome is an amnestic-confabulatory syndrome characterized by severe anterograde and retrograde amnesia that follows Wernicke encephalopathy; Korsakoff syndrome emerges as ocular manifestations and encephalopathy subside (174; 298; 184; 233; 150; 83; 229). Korsakoff syndrome is more likely to occur when Wernicke encephalopathy is a consequence of alcohol abuse (116). Rarely, Korsakoff syndrome may be present without Wernicke encephalopathy or may be present at the time of diagnosis of Wernicke encephalopathy (25; 289; 314). In Korsakoff syndrome, memory is disproportionately impaired relative to other aspects of cognitive function. A typical finding is a striking loss of working memory and relative preservation of implicit or procedural memory. These patients can learn new motor skills or develop conditioned reactions to stimuli. Disorientation to time may be present. Minor executive dysfunction may also be seen (33). Confabulation becomes less evident with time (150). Confabulation severity may be related to a worse outcome (218). Emotional changes may develop and include apathy or mild euphoria. Structural or neurochemical abnormalities within the limbic and diencephalic circuits likely account for anterograde amnesia. Lesions in the mammillary body, mammillothalamic tract, and the anterior thalamus may be more relevant to memory dysfunction than lesions in the medial dorsal nucleus of the thalamus (151). Frontal lobe dysfunction possibly underlies the severe retrograde memory loss and emotional changes found in this syndrome (150; 33).

Prognosis and complications

In wet beriberi, a rapid improvement is seen, with clearing of symptoms within days (211). Improvement in motor and sensory symptoms takes weeks or months (211; 148). Response in Wernicke encephalopathy is variable. Ophthalmoplegia improves rapidly, often so even with low doses of thiamine (55). A fine horizontal nystagmus may persist in up to 60% of patients. Gait disturbances improve over days. Mental status changes improve over days or weeks. Recovery of consciousness may be seen even in patients in deep coma (62). As the global confusional state recedes, some patients are left with Korsakoff syndrome. Prompt treatment of Wernicke encephalopathy prevents the development of Korsakoff syndrome. Korsakoff syndrome does not respond to thiamine therapy. Even with thiamine treatment, the mortality is about 20% (288; 164; 57; 282). Sudden death can occur and may be related to hemorrhagic brainstem lesions (108; 96).

Clinical vignette

A 41-year-old man with chronic diarrhea and vomiting presented with diplopia and unsteadiness. His examination was remarkable for partial ophthalmoplegia, gaze-evoked nystagmus, and gait ataxia. Brain MRI revealed increased FLAIR signal involving the midbrain periaqueductal gray matter. Thiamine administration (500 mg IV every 8 hours for 3 days followed by 100 mg IV daily) resulted in prompt resolution of ocular signs and symptoms and a gradual improvement in gait.

Biological basis

Etiology and pathogenesis

Thiamine deficiency can be seen in conditions associated with decreased intake, decreased absorption, defective transport, increased losses, and enhanced requirements (233; 244; 169). Thiamine deficiency is increasingly being recognized in nonalcoholics (79; 165; 188; 208; 77; 30; 87; 132; 62; 240; 228; 266; 102; 144; 220; 269). Often, multiple contributing factors may coexist. For example, thiamine deficiency may occur in a patient on parenteral nutrition who is experiencing recurrent vomiting following gastrointestinal surgery.

Thiamine deficiency is often seen in the setting of alcoholism and results from inadequate dietary intake, reduced gastrointestinal absorption, reduced liver thiamine stores, and impaired phosphorylation of thiamine to thiamine diphosphate (287; 120; 44; 234; 41; 281; 315). Additionally, alcohol metabolism raises the demand for thiamine. Studies have shown that ingestion of large amounts of alcohol does not result in Wernicke encephalopathy if dietary thiamine intake is adequate (253).

Gastrointestinal surgery directed at treating disorders like peptic ulcer disease, gastric or colon cancer, small-bowel obstruction, inflammatory bowel disease, achalasia, pancreatitis, and in particular obesity (bariatric surgery) can result in thiamine deficiency (104; 01; 250; 103; 54; 66; 148; 145; 94; 13; 238; 95; 129; 136; 168; 176; 265; 62; 19). Though rare, it can also be seen after sleeve gastrectomy (263). Preoperative thiamine deficiency in patients undergoing bariatric surgery has also been recognized (45; 89). Wernicke encephalopathy generally occurs 1 to 8 months after surgery. Thiamine deficiency has been reported as early as 2 weeks and as late as 28 years after gastrointestinal surgery (13; 134). It is particularly common with rapid weight loss (greater than 7 kg per month). Additional risk factors include inadequate dietary supplementation and recurrent vomiting (54). Atypical clinical features may be present when Wernicke encephalopathy is seen following bariatric surgery (265). Thiamine deficiency may also be seen in patients seeking bariatric surgery (137). A report noted Wernicke encephalopathy in a patient with cystic fibrosis, a disease typically associated with fact soluble vitamin deficiencies (299).

Thiamine deficiency may be seen with various causes of persistent vomiting and a broad spectrum of gastrointestinal, hepatic, or pancreatic diseases associated with chronic diarrhea. Wernicke encephalopathy has been reported with recurrent vomiting in pancreatitis, migraine attacks, hyperemesis gravidarum, and other conditions (205; 161; 309; 195; 90; 305; 209; 192; 188; 48; 49; 16; 193; 204; 219; 273; 69; 221). A review of hyperemesis gravidarum noted that clinically manifest thiamine depletion was seen between 10 to 15 weeks of gestation, before onset of Wernicke encephalopathy. Vomiting had been present in patients for a median of 7 weeks prior to Wernicke encephalopathy (219). This study also noted increased occurrence of loss of pregnancy and that thiamine supplementation given was often insufficient (219). Thiamine deficiency can result from dietary restriction as seen in starvation, prolonged fasting, hunger strikes, anorexia nervosa, liquid-only diets, various psychiatric disorders, psychogenic food refusal, dietary neglect in the aged, and in patients with Alzheimer disease (78; 67; 107; 224; 76; 46; 294; 133). An outbreak of beriberi occurred at a detention center in Abidjan (05). Extreme dieting followed by binge eating has also been known to precipitate Wernicke encephalopathy in anorexia nervosa (226). Poststroke malnutrition may be complicated by thiamine deficiency in the setting of parenteral glucose administration without thiamine (163).

Infant beriberi may be seen in infants who are breastfed by thiamine-deficient asymptomatic mothers. Maternal thiamine deficiency may result from eating a staple diet of polished rice with foods containing thiaminase or anti-thiamine compounds. Commercial dietary formula, slimming diets, ketogenic diets, and food fads can all cause thiamine deficiency (188; 245; 86; 85; 252; 251; 126). An additional cause of thiamine responsive disorder in the pediatric population is defect in the SLC19A3 gene, which causes thiamine transporter-2 deficiency (158; 217; 08). These disorders present with acute or recurrent encephalopathy in children and have collectively been referred to as biotin-thiamine-responsive basal ganglia disease. Imaging may show basal ganglia T2 hyperintensities and laboratory studies may reveal increased excretion of organic acids that are specific for thiamine-dependent mitochondrial enzymes, such as lactate, alpha-ketoglutarate, and branched-chain keto acids (80; 217). Clinical manifestations may also include seizures, dysarthria, dysphagia, supranuclear facial palsy, external ophthalmoplegia, dystonia, and quadriparesis (80). These conditions are potentially fatal or can be associated with significant neurologic morbidity. Mutations in SLC19A2 cause thiamine transporter-1 deficiency; the resulting disorder is characterized by thiamine responsive megaloblastic anemia, diabetes mellitus, and sensorineural hearing impairment (35; 169). Non-Amish SLC25A19 deficiency is characterized by acute episodes of fever-induced encephalopathy, lactic acidosis, and striatal necrosis; a milder presentation and basal ganglia involvement may antedate the acute encephalopathy permitting preventive therapy (230). Mutations in SLC25A19 affect the mitochondrial thiamine pyrophosphate transporter and result in Amish-type microcephaly or bilateral striatal necrosis with progressive peripheral neuropathy (35; 169). Another thiamine responsive disorder is due to TPK1 mutations (124). Some dietary supplements have herbal preparations that can interfere with thiamine absorption or act as thiamine antagonists (115). Certain raw fish and shellfish contain bacteria rich in thiaminases (300). These can inactivate thiamine in food, as can excessively cooking. Excess antacid use can interfere with thiamine absorption. Anti-thiamine factors are also present in betel nut, tea, and coffee (300; 197; 115). Excess amount of sulphites can destroy thiamine, and a Wernicke encephalopathy-like syndrome has been reported after prolonged feeding of dogs with sulphite-preserved meats (264).

Cancer, chemotherapy, and bone marrow transplantation are clinical settings in which Wernicke encephalopathy is being increasingly identified (227; 175; 28; 296; 91; 29; 190; 37). Malignancy is the most common underlying disorder associated with Wernicke encephalopathy in children (296). Chemotherapeutic agents like erbulozole and ifosfamide may interfere with conversion of thiamine to thiamine pyrophosphate (295; 131; 38). Intravenous thiamine can result in effective reversal of ifosfamide-induced encephalopathy (106; 123; 196). Wernicke encephalopathy may occur after 5-fluorouracil-based chemotherapy (50). Thiamine deficiency has rarely been reported following diuretic therapy with furosemide due to flushing out of water-soluble vitamins (200). Wernicke encephalopathy may coexist with toxidromes like the neuroleptic malignant syndrome (119).

Reports have noted thiamine deficiency in encephalopathic patients with COVID-19 infection (32). In one report, adjunctive therapy with thiamine in critically ill patients with COVID-19 was associated with survival benefit and a lower incidence of thrombosis (15). Weight loss and olfactory dysfunction following COVID-19 infection has also been reported to cause Wernicke encephalopathy (159). Stroke-like symptoms, a seventh nerve palsy, and neuroimaging findings suggestive of thiamine deficiency have been reported in a patient 2 days after testing positive for COVID-19 (11). Another patient presented with subacute vision loss due to thiamine deficiency following COVID-19 infection (255).

Wernicke encephalopathy has been reported after high-dose nitroglycerin infusion and was possibly a consequence of the effect of the diluents ethyl alcohol and propylene glycol on thiamine metabolism (261). Tolazamide can cause Wernicke encephalopathy by lowering thiamine levels in individuals with marginal stores (157).

Patients with renal failure, particularly when on peritoneal dialysis or hemodialysis may be susceptible to developing Wernicke encephalopathy (84; 171; 122; 121; 188; 114). Factors responsible may include reduced intake due to nausea and vomiting, accelerated thiamine loss during dialysis, presence of infections, and parenteral nutrition without adequate thiamine supplementation. In some patients, uremic encephalopathy may be associated with a high concentration of guanidinosuccinic acid (34). This compound may predispose patients to Wernicke encephalopathy by inhibiting transketolase.

Other systemic diseases that have been associated with thiamine deficiency include prolonged infectious febrile diseases and hyperthyroidism (81; 210; 30). In patients with a marginal nutritional status, increased metabolic demand as is seen in periods of vigorous exercise, hyperthyroidism, malignancy, and systemic infections may precipitate symptoms. Biochemical and pathological evidence of thiamine deficiency may be seen in AIDS with or without clinical manifestations (42; 10). Thiamine deficiency may be seen in critically ill patients receiving intensive care for a variety of reasons (249; 73; 179; 06). Thiamine supplementation in critically ill patients has been shown to reduce the incidence of ICU delirium (248).

Magnesium has a role as a cofactor in the conversion of thiamine into thiamine pyrophosphate and in the action of transketolase in the pentose phosphate pathway. Magnesium deficiency can predispose to the development of Wernicke encephalopathy and can be a cause of thiamine refractoriness in patients with Wernicke-Korsakoff syndrome (290; 185).

Relative thiamine deficiency may be seen in high-risk patients during periods of high carbohydrate intake as is seen with nasogastric feeding, total parenteral nutrition, or intravenous hyperalimentation (20; 199; 152; 170; 303; 224; 143; 95; 190). In these circumstances, a high percentage of calories is derived from glucose, and the amount of corresponding thiamine replacement is inadequate. This is particularly common when there is preceding starvation or where several days of intravenous nutrition without adequate vitamin replacement is followed by oral food intake (78; 257). This “refeeding syndrome” is an additional risk factor for thiamine deficiency and may have been an explanation for sudden death seen in prisoners of war (233; 228; 36). Wernicke encephalopathy secondary to anorexia nervosa complicated by refeeding syndrome can be associated with a takotsubo cardiomyopathy (36).

Postulated factors that may predispose to the development of Wernicke-Korsakoff syndrome while on a marginal thiamine diet include individual variations in the biochemical activity of transketolase, variations in transketolase affinity for thiamine, susceptibility mediated by GABAA receptor subunit gene cluster, changes in thiamine transport systems, variants in genes encoding enzymes involved in alcohol metabolism, and gene polymorphisms with a potential modifying effect (26; 27; 162; 244).

Thiamine deficiency leads to brain lesions in selective vulnerable areas that have a high thiamine content and turnover (such as the caudal brain and cerebellum) (235). It has been suggested that given the daily requirement of thiamine of approximately 1 to 2 mg per day, and body stores of approximately 30 to 50 mg, it takes approximately 4 to 6 weeks for body stores to be depleted (283). A severe thiamine-deficient diet may result in depletion of body stores, reduced blood thiamine levels, clinical manifestations of thiamine deficiency, and related brain lesions in as early as 2 to 3 weeks (242; 267). This may occur even earlier in individuals with marginal stores, particularly so if the diet is rich in carbohydrates (143).

It has been suggested that decreased alpha-ketoglutarate dehydrogenase, rather than decreased pyruvate dehydrogenase complex, constitutes the primary biochemical lesion in thiamine deficiency encephalopathy (40; 41; 113; 112). Alpha-ketoglutarate dehydrogenase is the rate-limiting enzyme in the tricarboxylic acid cycle that is involved in the synthesis of high-energy phosphates. Decreased alpha-ketoglutarate dehydrogenase activity in astrocytes is the earliest biochemical change and has been noted after 4 days of experimental thiamine deficiency (pyrithiamine-induced thiamine deficiency) (112). This is also the “reversible biochemical lesion” stage. Reduction in transketolase activity is noted after 7 days, and reduction in pyruvate dehydrogenase is noted after 10 days. Impaired pyruvate dehydrogenase activity impairs conversion of pyruvate into acetyl CoA and increases lactate production. Glucose loading has been shown to precipitate focal lactic acidosis in the vulnerable medial thalamus of thiamine-deficient rats (202).

These biochemical events result in reduced cerebral glucose utilization and impaired cellular energy metabolism (105). Thiamine-deficient membranes are unable to maintain osmotic gradients. Intracellular and extracellular swelling results. Astrocyte-related functions are impaired. These include intracellular and extracellular glutamate concentrations, maintenance of ionic gradients across cell membranes, and blood-brain barrier permeability (113). Proposed mechanisms that lead to neurotoxicity also include glutamate-mediated excitotoxicity, DNA fragmentation and apoptotic cell death, decreased synaptic transmission, mitochondrial dysfunction, and intracellular oxidative stress with free radical and cytokine production (40; 41; 183; 285; 286; 77; 244).

Due to the rapid turnover rates and absence of significant storage amounts, a continuous dietary supply of thiamine is necessary. Parenteral administration of thiamine creates a steep concentration gradient between the plasma and brain. This facilitates passive diffusion and rapid correction of brain thiamine deficiency (282). The half-life of thiamine after intravenous administration is 96 minutes, whereas the elimination half-life after oral administration is 154 minutes (277). In a healthy individual, the calculated maximum amount of thiamine that can be absorbed from a single oral dose is about 4.5 mg, and in an individual with chronic malabsorption this amount is reduced by 70% (282). These pharmacokinetic factors explain the need for 3-times-a-day dosing of thiamine by the parenteral route in patients with Wernicke encephalopathy or in patients at risk of Wernicke encephalopathy.

Pathology

Beriberi. Pathologic studies of beriberi in nonalcoholics are limited (211). Axonal degeneration has been noted in distal nerves. Chromatolysis of dorsal root ganglion neurons and anterior horn cell neurons may be seen due to axonal degeneration. Segmental demyelination is rare and likely secondary to axonal degeneration. Severe cases may have involvement of the vagus and phrenic nerves. Degeneration of the posterior columns may be present.

Wernicke encephalopathy. Wernicke encephalopathy is commonly underdiagnosed. The frequency of Wernicke encephalopathy in various autopsy studies ranges from 0.8% to 2.8%, far in excess of what would be expected from clinical studies (61; 298; 108; 109; 288; 233; 110; 165; 296). The underdiagnosis is particularly common in children, alcoholics, patients with AIDS, and with coexisting hepatic encephalopathy or alcohol intoxication. The clinical features of Wernicke encephalopathy may be difficult to differentiate from alcohol intoxication. In a neuropathological series of 131 cases, only 20% were diagnosed during life (109; 110).

The neuropathologic changes in Wernicke encephalopathy involve the mammillary bodies, hypothalamus and thalamus, superior cerebellar vermis, brainstem (including the periaqueductal grey matter, pontine tegmentum, and midbrain reticular formation), walls of the third ventricle, and floor of the fourth ventricle (298; 153). There is involvement of the third and sixth nerve nuclei, vestibular nuclei, locus ceruleus, and, rarely, vagal nuclei. Also described is involvement of the colliculi, fornices, septal region, hippocampi, and cerebral cortex. In Wernicke encephalopathy the characteristic finding is mammillary body involvement; patients with Korsakoff syndrome typically have involvement of the dorsal median nucleus of the thalamus. In a nonhuman primate model of thiamine deficiency lesions involving the inferior colliculi were the earliest findings (Witt and Goldman-Rakic 1983).

A symmetric grayish discoloration involving the periaqueductal grey matter, mamillary bodies, and medial thalami is typically seen and is accompanied by congestion and pinpoint hemorrhages (298). Gross hemorrhage is rare. Microscopically acute lesions are characterized by multiple small hemorrhages with intervening spongiosis and edema without interstitial infiltration or capillary proliferation (298). Prominent vessels result from hypertrophy and hyperplasia. Extravasated red blood cells and hemosiderin-laden macrophages may be seen. Chronic lesions show loosening of the neuropil accompanied by activated microglia, reactive astrocytes, gliosis, and vascular proliferation. There is relative neuronal and axonal sparing.

Prevention

Intravenous glucose infusion in patients with thiamine deficiency may consume the available thiamine and precipitate an acute Wernicke encephalopathy (241). At-risk patients should receive parenteral thiamine prior to administration of glucose or parenteral nutrition.

Parenteral thiamine administration in Wernicke encephalopathy is commonly employed; the available guidelines, however, vary in their recommendations, and there are limited evidence-based recommendations for thiamine use in patients with alcohol use disorder (231; 268; 68). Thiamine supplementation is, however, underutilized in patients with alcohol use disorder or patients with critical illness (222).

Patients suspected of having beriberi or Wernicke encephalopathy should promptly receive parenteral thiamine, intravenously or intramuscularly. It has been suggested that a large amount of thiamine supplementation may be harmful for cancer patients because it could promote tumor cell growth (31). The clinical significance of this requires further studies. Adverse effects are rare and include pruritus, transient local irritation, or, rarely, anaphylaxis. These occur during or shortly after parenteral administration, more so with intravenous administration. Thiamine supplementation has been reported to cause normonatremic central pontine myelinolysis (141; 316). Thiamine for parenteral use should be diluted in 100 mL of normal saline or 5% glucose and be infused over 30 minutes (57; 282). The thiamine solution should be freshly prepared. Old solutions exposed to heat may be inactivated (233).

A commonly used thiamine replacement regimen is 100 mg intravenously every 8 hours for 3 to 5 days (94; 160; 92). A Cochrane review suggests that clinically significant thiamine deficiency be treated with at least 200 mg of parenteral thiamine daily for 2 days (64). Higher doses may be required in Wernicke encephalopathy, particularly when Wernicke encephalopathy occurs in the setting of alcoholism (284). A clear benefit of higher dosing has not been demonstrated (68). Lower doses may suffice with predominantly nutritional thiamine deficiency. It has been suggested that patients with signs of Wernicke encephalopathy should receive 500 mg thiamine hydrochloride (diluted in 100 mL of normal saline) by infusion over 30 minutes, three times a day, for 2 to 3 days (57; 118; 56; 281; 282; 283; 284; 244; 220). Subsequently, the dose may be reduced to 250 mg of thiamine given intravenously or intramuscularly daily for 3 to 5 days. Similar doses may be given prophylactically in conditions of alcohol withdrawal or severe malnutrition. The parenteral form is used when there is doubt about adequate gastrointestinal absorption. Long-term oral maintenance with 50 to 100 mg thiamine is commonly employed. Higher enteral thiamine intake is not toxic (118). A lipophilic form of thiamine (benfotiamine) has been used in chronic alcoholism-related neuropathy in a dose of 320 mg/day for 4 weeks followed by 120 mg/day for an additional 3 weeks (307).

Wernicke encephalopathy often develops in a predisposed individual because of increased metabolic demands related to coexisting conditions, like an infection, that need independent attention. Deficiency of other vitamins, like niacin, need correction; niacin deficiency causes an encephalopathy indistinguishable from Wernicke encephalopathy. Magnesium deficiency leads to a refractory response to thiamine and if present needs concurrent correction (290; 185; 244; 60).

Diagnostic workup

Urine and blood. Wernicke encephalopathy is largely a clinical diagnosis (172). Urinary thiamine excretion and serum thiamine levels may be decreased in Wernicke encephalopathy, but they do not accurately reflect tissue concentrations and are, therefore, not reliable indicators of thiamine status. Whole blood thiamine levels are more sensitive than plasma thiamine. A low blood thiamine level may also identify patients at risk of developing Wernicke encephalopathy. Thirty percent to 80% of alcoholics may have low levels of thiamine (57). The erythrocyte transketolase activation assay is an assay of functional status and is based on measurement of transketolase activity in hemolysates of red blood cells in the absence of (and in the presence of) added excess cofactor (thiamine diphosphate) (278). It is an indirect assessment with limited specificity as factors other than thiamine deficiency can decrease transketolase activity. Thiamine diphosphate is the active form of thiamine. It is present in erythrocytes and measurement of thiamine diphosphate in human erythrocytes by high-performance liquid chromatography has improved reproducibility and is suitable for clinical and research purposes (177). Because these laboratory abnormalities normalize quickly, a blood sample should be drawn before initiation of treatment. An anion-gap metabolic acidosis accompanied by a primary respiratory alkalosis may be present (74). Thiamine deficiency may manifest as unexplained metabolic acidosis (272).

CSF and EEG. CSF may show raised protein concentration in later stages (244). EEG may show nonspecific slowing (244). Rarely, epileptiform activity may be present on EEG (Mengi and Beckman 2022).

CT. CT has poor sensitivity and is of limited utility. Low-density abnormalities may be seen in the paraventricular regions of the thalamus (17; 296).

MRI. MRI is the imaging modality of choice. MRI abnormalities may be dependent on timing and dose of thiamine administration with higher doses and earlier correction being associated with lesser chances of abnormal imaging (262). In one series, MRI was noted to have a sensitivity and specificity of 53% and 93%, respectively (17). It is important to remember that it is not uncommon for the brain MRI to be normal (191). Typical MRI findings include increased T2 or proton density or FLAIR signal in the paraventricular region of the thalamus, hypothalamus, mammillary body, periaqueductal midbrain, tectal plate, pons, fourth ventricle floor, medulla, midline cerebellum, and, rarely, in the splenium of the corpus callosum or caudate and other basal ganglia structures (98; 297; 209; 173; 275; 17; 63; 259; 21; 70; 77; 304; 319; 91; 293; 88; 236; 189; 114). Signal alterations involving the red nucleus, dentate, or substantia nigra have rarely been reported (130). Increased signal may involve the hypoglossal, medial vestibular, facial, abducens, red, and dentate nuclei (321; 322; 324). Involvement of cortical regions on MRI has also been reported (297; 312; 63; 138; 70; 94; 319; 87; 62). Cortical involvement and selective involvement of cranial nerve nuclei are features of nonalcoholic Wernicke encephalopathy (322; 324). These changes are seen in conjunction with the more typical sites of involvement that have been described in alcoholic Wernicke encephalopathy. Cerebellar involvement may be seen in either alcoholic or nonalcoholic Wernicke encephalopathy. Cortical involvement may indicate irreversible lesions and poor prognosis (319; 87; 225). A study of MRI in patients with nonalcoholic Wernicke encephalopathy noted that patients with no disturbance in consciousness or only drowsiness had lesions confined to the periaqueductal area and patients with lethargy or mild coma had the more typical MR appearance of paraventricular involvement (87). In another study of MRI in nonalcoholic Wernicke encephalopathy, medial thalami and caudate involvement was noted in comatose patients (319). Contrast enhancement may be present in the early stages (243; 260; 181; 259; 21; 304; 94). Mammillary body enhancement on MR has been reported as being the only imaging abnormality in Wernicke encephalopathy (260). Hemorrhagic lesions are rare (243; 216; 258). In one report, midbrain swelling was accompanied by hydrocephalus that required shunting (77). In another report, periaqueductal swelling resulted in hydrocephalus that improved with thiamine replacement; that patient also had hemorrhage involving both inferior colliculi (258). Bilateral anterior thalami and fornix macrohemorrhage have been reported in Wernicke-Korsakoff syndrome (203). Though rare, intraventricular hemorrhage may also be seen (09). Susceptibility-weighted MRI may show cortical laminar necrosis and hemorrhage (225). The neuropathology corresponding to the T2-signal change is spongy degeneration of the neuropil (275). The signal abnormalities resolve with treatment, but shrunken mamillary bodies may persist as sequelae. Additional findings in the chronic stages include dilated aqueduct and third ventricles with atrophy of the midbrain tegmentum, and paramedian thalamic nuclei (47; 313). Frontal or generalized or vermian atrophy may also be seen (319).

In patients with Wernicke encephalopathy, abnormalities may be seen on diffusion-weighted MRI in the early stages (276; 21; 212; 52; 70; 117; 53). These may disappear after successful thiamine therapy, suggesting underlying vasogenic edema. Both cytotoxic and vasogenic edema may be concurrently present (293; 236). The abnormalities attributed to cytotoxic edema may also be reversible (52). Proton MR spectroscopy may show evidence of lactate accumulation (237).

Neuroimaging in biotin-thiamine-responsive basal ganglia disease shows variable degrees of signal change in the basal ganglia, thalamus, cerebellum, and brainstem (07).

References

01: Abarbanel JM, Berginer VM, Osimani A, Solomon H, Charuzi I. Neurologic complications after gastric restriction surgery for morbid obesity. Neurology 1987;37:196-200. PMID 3027610
02: Ackerman WJ. Stupor, bradycardia, hypotension and hypothermia. A presentation of Wernicke's encephalopathy with rapid response to thiamine. West J Med 1974;121:428-9. PMID 4460385
03: Aguiar AC, Costa VM, Ragazzo PC, et al. Mielinolise pontina e extra-pontina associada a Shoshin beriberi em paciente etilista. Arq Neuropsiquiatr 2004;62:733-6. PMID 15334241
04: Ahmed S, Akadiri TV, Ata S, Ayub S. An unusual presentation of catatonia in non-alcoholic Wernicke encephalopathy. Cureus 2021;13:e12537. PMID 33564534
05: Ahoua L, Etienne W, Fermon F, et al. Outbreak of beriberi in a prison in Cote d'Ivoire. Food Nutr Bull 2007;28(3):283-90. PMID 17974361
06: Akkuzu E, Yavuz S, Ozcan S, et al. Prevalence and time course of thiamine deficiency in critically ill children: a multicenter, prospective cohort study in Turkey. Pediatr Crit Care Med 2022;23(5):399-404. PMID 35583619
07: Alsini H, Alnozha A, Asmat Z, Hundallah K, Alfadhel M, Tabarki B. Beyond the caudate nucleus: Early atypical neuroimaging findings in biotin-thiamine- responsive basal ganglia disease. Brain Dev 2022;44(9):618-22. PMID 35811190
08: Al-Anezi A, Sotirova-Koulli V, Shalaby O, et al. Biotin-thiamine responsive basal ganglia disease in the era of COVID-19 outbreak diagnosis not to be missed: A case report. Brain Dev 2022;44(4):303-7. PMID 34953623
09: Al-Bayati AR, Nichols J, Jovin TG, Jadhav AP. Thiamine deficiency presenting as intraventricular hemorrhage. Stroke 2016;47(6):e95-7. PMID 27165958
10: Alcaide ML, Jayaweera D, Espinoza L, Kolber M. Wernicke's encephalopathy in AIDS: a preventable cause of fatal neurological deficit. Int J STD AIDS 2003;14:712-3. PMID 14596777
11: Alexandri M, Reynolds BZ, Smith H, Golden BM, Gross H, Switzer JA. Wernicke's encephalopathy and cranial nerve VII palsy in a 24-year-old patient with COVID-19. Int J Emerg Med 2022;15(1):6. PMID 35090396
12: Alfadhel M, Almuntashri M, Jadah RH, et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis 2013;8:83. PMID 23742248
13: Al-Fahad T, Ismael A, Soliman MO, Khoursheed M. Very early onset of Wernicke's encephalopathy after gastric bypass. Obes Surg 2006;16:671-2. PMID 16687041
14: Algahtani H, Ghamdi S, Shirah B, Alharbi B, Algahtani R, Bazaid A. Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment. Neurol Res 2017;39(2):117-25. PMID 27905264
15: Al Sulaiman K, Aljuhani O, Al Dossari M, et al. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study. Crit Care 2021;25(1):223. PMID 34193235
16: Aneja T, Chaturvedula L, Nair PP, Barathi D, Keepanasseril A. Complete recovery in Wernicke's encephalopathy complicating hyperemesis gravidarum. BMJ Case Rep 2019;12(2). PMID 30737323
17: Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol 1998;171:1131-7. PMID 9763009
18: Aycan Z, Bas VN, Cetinkaya S, Agladioglu SY, Kendirci HN, Senocak F. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report. J Pediatr Hematol Oncol 2011;33(2):144-7. PMID 21285901
19: Bahardoust M, Eghbali F, Shahmiri SS, et al. B1 vitamin deficiency after bariatric surgery, prevalence, and symptoms: a systematic review and meta-analysis. Obes Surg 2022;32(9):3104-12. PMID 35776243
20: Baughman FA Jr, Papp JP. Wernicke's encephalopathy with intravenous hyperalimentation: remarks on similarities between wernicke's encephalopathy and the phosphate depletion syndrome. Mt Sinai J Med 1976;43:48-52. PMID 813111
21: Bergui M, Bradac GB, Zhong JJ, Barbero PA, Durelli L. Diffusion-weighted MR in reversible Wernicke encephalopathy. Neuroradiology 2001;43:969-72. PMID 11760803
22: Bertrand A, Brandel JP, Grignon Y, et al. Wernicke encephalopathy and Creutzfeldt-Jakob disease. J Neurol 2009;256(6):904-9. PMID 19252796
23: Bettendorff L. Thiamine in excitable tissues: reflections on a non-cofactor role. Metab Brain Dis 1994;9:183-209. PMID 7838063
24: Birchfield RI. Postural hypotension in Wernicke's disease. a manifestation of autonomic nervous system involvement. Am J Med 1964;36:404-14. PMID 14131885
25: Blansjaar BA, Van Dijk JG. Korsakoff minus Wernicke syndrome. Alcohol Alcohol 1992;27:435-7. PMID 1418116
26: Blass JP, Gibson GE. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med 1977;297:1367-70. PMID 927453
27: Blass JP, Gibson GE. Genetic factors in Wernicke-Korsakoff syndrome. Alcohol Clin Exp Res 1979;3:126-34. PMID 391073
28: Bleggi-Torres LF, de Medeiros BC, Ogasawara VS, et al. Iatrogenic Wernicke's encephalopathy in allogeneic bone marrow transplantation: a study of eight cases. Bone Marrow Transplant 1997;20:391-5. PMID 9339755
29: Boniol S, Boyd M, Koreth R, Burton GV. Wernicke encephalopathy complicating lymphoma therapy: case report and literature review. South Med J 2007;100:717-9. PMID 17639753
30: Bonucchi J, Hassan I, Policeni B, Kaboli P. Thyrotoxicosis-associated Wernicke’s encephalopathy. J Gen Intern Med 2008;23:106-9. PMID 18026802
31: Boros LG, Brandes JL, Lee WN, et al. Thiamine supplementation to cancer patients: a double edged sword. Anticancer Res 1998;18:595-602. PMID 9568183
32: Branco de Oliveira MV, Irikura S, Lourenco FHB, et al. Encephalopathy responsive to thiamine in severe COVID-19 patients. Brain Behav Immun Health 2021;14:100252. PMID 33817670
33: Brokate B, Hildebrandt H, Eling P, et al. Frontal lobe dysfunctions in Korsakoff's syndrome and chronic alcoholism: continuity or discontinuity. Neuropsychology 2003;17:420-8. PMID 25690971
34: Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004;107:1-16. PMID 15567546
35: Brown G. Defects of thiamine transport and metabolism. J Inherit Metab Dis 2014;37(4):577-85. PMID 24789339
36: Brown K, Everwine M, Nieves J. A case of Wernicke encephalopathy secondary to anorexia nervosa complicated by refeeding syndrome and Takotsubo cardiomyopathy. Am J Case Rep 2021;22:e929891. PMID 33720925
37: Brown S, Hutt-Williams S. Wernicke's encephalopathy in advanced cancer. BMJ Support Palliat Care 2022;12(4):460-2. PMID 35831181
38: Buesa JM, Garcia-Teijido P, Losa R, Fra J. Treatment of ifosfamide encephalopathy with intravenous thiamin. Clin Cancer Res 2003;9:4636-7. PMID 14555540
39: Buscaglia J, Faris J. Unsteady, unfocussed, and unable to hear. Am J Med 2005;118:1215-7. PMID 16271902
40: Butterworth RF. Cerebral thiamine-dependent enzyme changes in experimental Wernicke's encephalopathy. Metab Brain Dis 1986;1:165-75. PMID 3334065
41: Butterworth RF. Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome. Alcohol Alcohol 1989;24:271-9. PMID 2675860
42: Butterworth RF, Gaudreau C, Vincelette J, et al. Thiamine deficiency and Wernicke's encephalopathy in AIDS. Metab Brain Dis 1991;6:207-12. PMID 1812394
43: Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997;62:51-60. PMID 9010400
44: Camilo ME, Morgan MY, Sherlock S. Erythrocyte transketolase activity in alcoholic liver disease. Scand J Gastroenterol 1981;16:273-9. PMID 7313539
45: Carrodeguas I, Kaidar-Person O, Szomstein S, Antozi P, Rosenthal R. Preoperative thiamine deficiency in obese population undergoing laproscopic bariatric surgery. Surg Obes Relat Dis 2005;1:517-22. PMID 16925281
46: Casanova MF. Wernicke's disease and schizophrenia: a case report and review of the literature. Int J Psychiatry Med 1996;26:319-28. PMID 8976472
47: Charness ME, DeLaPaz RL. Mamillary body atrophy in Wernicke's encephalopathy: antemortem identification using magnetic resonance imaging. Ann Neurol 1987;22:595-600. PMID 3426166
48: Chiossi G, Neri I, Cavazzuti M, Basso G, Facchinetti F. Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv 2006;61:255-68. PMID 16551377
49: Chitra S, Lath KV. Wernicke's encephalopathy with visual loss in a patient with hyperemesis gravidarum. J Assoc Physicians India 2012;60:53-6. PMID 23029727
50: Cho IJ, Chang HJ, Lee KE, et al. A case of Wernicke’s encephalopathy following fluorouracil-based chemotherapy. J Korean Med Sci 2009;24:747-50. PMID 19654964
51: Choi KD, Oh SY, Kim HJ, Kim JS. The vestibulo-ocular reflexes during head impulse in Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 2007;78:1161-2. PMID 17578853
52: Chu K, Kang DW, Kim HJ, Lee YS, Park SH. Diffusion-weighted imaging abnormalities in wernicke encephalopathy: reversible cytotoxic edema. Arch Neurol 2002;59:123-7. PMID 11790239
53: Chung TI, Kim JS, Park SK, et al. Diffusion weighted MR imaging of acute Wernicke's encephalopathy. Eur J Radiol 2003;45:256-58. PMID 12595110
54: Cirignotta F, Manconi M, Mondoni S, Buzzi G, Ambrosetto P. Wernicke-Korsakoff encephalopathy and polyneuropathy after gastroplasty for morbid obesity. Arch Neurol 2000;57:1356-9. PMID 10987905
55: Cole M, Turner A, Frank O, Baker H, Leevy CM. Extraocular palsy and thiamine therapy in Wernicke's encephalopathy. Am J Clin Nutr 1969;22:44-51. PMID 5764630
56: Cook CC. Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl 2000;35:19-20. PMID 11304070
57: Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998;33:317-36. PMID 9719389
58: Cooke CA, Hicks E, Page AB, Mc Kinstry S. An atypical presentation of Wernicke's encephalopathy in an 11-year-old child. Eye 2006;20:1418-20. PMID 16470217
59: Cornea A, Lata I, Simu M, Rosca EC. Wernicke encephalopathy presenting with dysphagia: a case report and systematic literature review. Nutrients 2022;14(24):5294. PMID 36558453
60: Coughlan JJ, Mross T, Wafer M, Liston R. Thiamine refractory Wernickes encephalopathy reversed with magnesium therapy. BMJ Case Rep 2016;2016. PMID 27797884
61: Cravioto H, Korein J, Silberman J. Wernicke's encephalopathy. A clinical and pathological study of 28 autopsied cases. Arch Neurol 1961;4:510-9. PMID 13696292
62: Cui HW, Zhang BA, Peng T, Liu Y, Liu YR. Wernicke's encephalopathy in a patient with acute pancreatitis: unusual cortical involvement and marvelous prognosis. Neurol Sci 2012;33(3):615-8. PMID 21918877
63: D'Aprile P, Tarantino A, Santoro N, Carella A. Wernicke's encephalopathy induced by total parenteral nutrition in patient with acute leukaemia: unusual involvement of caudate nuclei and cerebral cortex on MRI. Neuroradiology 2000;42:781-3. PMID 11110087
64: Day E, Bentham P, Callaghan R, Kuruvilla T, George S. Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev 2004;(1):CD004033. PMID 14974055
65: de la Cruz-Cosme C, Padilla-Parrado F, Garcia-Casares N, et al. Miller Fisher syndrome as the presenting symptom of Wernicke’s encephalopathy. Rev Neurol 2008;46(8):472-5. PMID 18428104
66: Deb S, Law-Min R, Fearnley D. Wernicke-Korsakoff syndrome following small bowel obstruction. Behav Neurol 2001;13:89-94. PMID 12446948
67: Devathasan G, Koh C. Wernicke's encephalopathy in prolonged fasting. Lancet 1982;2:1108-9. PMID 6127574
68: Dingwall KM, Delima JF, Binks P, Batey R, Bowden SC. What is the optimum thiamine dose to treat or prevent Wernicke's Encephalopathy or Wernicke-Korsakoff Syndrome?: Results of a randomised controlled trial. Alcohol Clin Exp Res 2022;46(6):1133-47. PMID 35428992
69: Divya MB, Kubera NS, Jha N, Jha AK, Thabah MM. Atypical neurological manifestations in Wernicke's encephalopathy due to hyperemesis gravidarum. Nutr Neurosci 2021:1-6. PMID 34042559
70: Doherty MJ, Watson NF, Uchino K, Hallam DK, Cramer SC. Diffusion abnormalities in patients with Wernicke encephalopathy. Neurology 2002;58:655-7. PMID 11865152
71: Donnan GA, Seeman E. Coma and hypothermia in Wernicke's encephalopathy. Aust N Z J Med 1980;10:438-9. PMID 6932837
72: Donnino M. Gastrointestinal beriberi: a previously unrecognized syndrome. Ann Intern Med 2004;141:898-9. PMID 15583247
73: Donnino MW, Carney E, Cocchi MN, et al. Thiamine deficiency in critically ill patients with sepsis. J Crit Care 2010;25(4):576-81. PMID 20646908
74: Donnino MW, Miller J, Garcia AJ, McKee E, Walsh M. Distinctive acid-base pattern in Wernicke's encephalopathy. Ann Emerg Med 2007a;50:722-5. PMID 17145109
75: Donnino MW, Vega J, Miller J, Walsh M. Myths and misconceptions of Wernicke’s encephalopathy: what every physician should know. Ann Emg Med 2007b;50:715-21. PMID 17681641
76: Doraiswamy PM, Massey EW, Enright K, et al. Wernicke-Korsakoff syndrome caused by psychogenic food refusal: MR findings. AJNR Am J Neuroradiol 1994;15:594-6. PMID 8197964
77: Doss A, Mahad D, Romanowski CA. Wernicke encephalopathy: unusual findings in nonalcoholic patients. J Comput Assist Tomogr 2003;27:235-40. PMID 12703018
78: Drenick EJ, Joven CB, Swendseid ME. Occurrence of acute Wernicke's encephalopathy during prolonged starvation for the treatment of obesity. N Engl J Med 1966;274:937-9. PMID 5908887
79: Ebels EJ. Underlying illness in Wernicke's encephalopathy. Analysis of possible causes of under-diagnosis. Eur Neurol 1974;12:226-8. PMID 4426324
80: Eichler FS, Swoboda KJ, Hunt AL, Cestari DM, Rapalino O. Case 38-2017. A 20-year-old woman with seizures and progressive dystonia. N Engl J Med 2017;377(24):2376-85. PMID 29236641
81: Enoch BA, Williams DM. An association between Wernicke's encephalopathy and thyrotoxicosis. Postgrad Med J 1968;44:923-4. PMID 5738050
82: Faigle R, Mohme M, Levy M. Dry beriberi mimicking Guillain-Barre syndrome as the first presenting sign of thiamine deficiency. Eur J Neurol 2012;19(2):e14-5. PMID 22136604
83: Fama R, Pfefferbaum A, Sullivan EV. Visuoperceptual learning in alcoholic Korsakoff syndrome. Alcohol Clin Exp Res 2006;30:680-7. PMID 16573587
84: Faris AA. Wernicke's encephalopathy in uremia. Neurology 1972;22:1293-7. PMID 4631350
85: Fattal-Valevski A, Bloch-Mimouni A, Kivity S, et al. Epilepsy in children with infantile thiamine deficiency. Neurology 2009;73:828-33. PMID 19571254
86: Fattal-Valevski A, Kesler A, Sela BA, et al. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics 2005;115:e233-8. PMID 15687431
87: Fei GQ, Zhong C, Jin L, et al. Clinical characteristics and MR imaging features of nonalcoholic Wernicke encephalopathy. AJNR Am J Neuroradiol 2008;29:164-9. PMID 18192344
88: Flabeau O, Foubert-Samier A, Meissner W, Tison F. Hearing and seeing: unusual early signs of Wernicke encephalopathy. Neurology 2008;71:694. PMID 18725598
89: Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 2006;10:1033-7. PMID 16843874
90: Flannelly G, Turner MJ, Connolly R, Stronge JM. Persistent hyperemesis gravidarum complicated by Wernicke's encephalopathy. Ir J Med Sci 1990;159:82. PMID 2361826
91: Flint AC, Anziska Y, Rausch ME, Herzog TJ, Williams O. A clinical and radiographic variant of Wernicke-Korsakoff syndrome in a nonalcoholic patient. Neurology 2006;67:2015. PMID 17159109
92: Flynn A, Macaluso M, D'Empaire I, Troutman MM. Wernicke's encephalopathy: increasing clinician awareness of this serious, enigmatic, yet treatable disease. Prim Care Companion CNS Disord 2015;17(3). PMID 26644959
93: Ford JE, Zechalko A, Murphy J, Brooke OG. Comparison of the B vitamin composition of milk from mothers of preterm and term babies. Arch Dis Child 1983;58:367-72. PMID 6859917
94: Foster D, Falah M, Kadom N, Mandler R. Wernicke encephalopathy after bariatric surgery: losing more than just weight. Neurology 2005;65:1987. PMID 16380628
95: Francini-Pesenti F, Brocadello F, Famengo S, Nardi M, Caregaro L. Wernicke's encephalopathy during parenteral nutrition. JPEN J Parenter Enteral Nutr 2007;31:69-71. PMID 17202444
96: Fried RT, Levy M, Leibowitz AB, et al. Wernicke’s encephalopathy in the intensive care patient. Crit Care Med 1990;18:779-80. PMID 2364722
97: Friel JK, Andrews WL, Simmons BS, et al. Evaluation of full-term infants fed an evaporated milk formula. Acta Paediatr 1997;86:448-53. PMID 9183479
98: Gallucci M, Bozzao A, Splendiani A, Masciocchi C, Passariello R. Wernicke encephalopathy: MR findings in five patients. AJR Am J Roentgenol 1990;155:1309-14. PMID 2122685
99: Galvin R, Brathen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA; EFNS. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol 2010;17(12):1408-18. PMID 20642790
100: Ghez C. Vestibular paresis: a clinical feature of Wernicke's disease. J Neurol Neurosurg Psychiatry 1969;32:134-9. PMID 5305749
101: Ghosh R, Mandal A, Roy D, et al. Seizure as a presenting manifestation of Wernicke's encephalopathy induced by hyperemesis gravidarum. J Family Med Prim Care 2021;10(1):567-71. PMID 34017792
102: Gomes F, Bergeron G, Bourassa MW, Fischer PR. Thiamine deficiency unrelated to alcohol consumption in high-income countries: a literature review. Ann N Y Acad Sci 2021;1498(1):46-56. PMID 33576090
103: Grace DM, Alfieri MA, Leung FY. Alcohol and poor compliance as factors in Wernicke's encephalopathy diagnosed 13 years after gastric bypass. Can J Surg 1998;41:389-92. PMID 9793507
104: Haid RW, Gutmann L, Crosby TW. Wernicke-Korsakoff encephalopathy after gastric plication. JAMA 1982;247:2566-7. PMID 7069924
105: Hakim AM, Pappius HM. Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency. Ann Neurol 1983;13:365-75. PMID 6838172
106: Hamadani M, Awan F. Role of thiamine in managing ifosfamide-induced encephalopathy. J Oncol Pharm Pract 2006;12:237-9. PMID 17156595
107: Handler CE, Perkin GD. Anorexia nervosa and Wernicke's encephalopathy: an underdiagnosed association. Lancet 1982;2:771-2. PMID 6125841
108: Harper C. Wernicke's encephalopathy: a more common disease than realised: a neuropathological study of 51 cases. J Neurol Neurosurg Psychiatry 1979;42:226-31. PMID 438830
109: Harper C. The incidence of Wernicke's encephalopathy in Australia: a neuropathological study of 131 cases. J Neurol Neurosurg Psychiatry 1983;46:593-8. PMID 6886695
110: Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49:341-5. PMID 3701343
111: Hayano S, Amamoto M, Naito E. Thiamine-responsive pyruvate dehydrogenase complex deficiency presenting as recurrent muscle weakness: Identification of a novel mutation (p.T111I) in the PDHA1 gene. Pediatr Int 2023;65(1):e15385. PMID 36225105
112: Hazell AS, Pannunzio P, Rama Rao KV, Pow DV, Rambaldi A. Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes. Glia 2003;43:175-84. PMID 12838509
113: Hazell AS, Todd KG, Butterworth RF. Mechanisms of neuronal cell death in Wernicke's encephalopathy. Metab Brain Dis 1998;13:97-122. PMID 9699919
114: Hidaka M, Kumamoto M, Suenaga T, et al. Wernicke-Korsakoff Syndrome in a Young Adult on Dialysis Who Showed Bilateral Ganglia Lesions. Internal Med 2023;62(1):113-8. PMID 35598991
115: Hilker DM, Somogyi JC. Antithiamins of plant origin: their chemical nature and mode of action. Ann N Y Acad Sci 1982;378:137-45. PMID 7044222
116: Homewood J, Bond NW. Thiamin deficiency and Korsakoff's syndrome: failure to find memory impairments following nonalcoholic Wernicke's encephalopathy. Alcohol 1999;19:75-84. PMID 10487391
117: Hong KS, Kang DW, Cho YJ, Hwang YJ, Hur G. Diffusion-weighted magnetic resonance imaging in Wernicke's encephalopathy. Acta Neurol Scand 2002;105:132-4. PMID 11903125
118: Hope LC, Cook CC, Thomson AD. A survey of the current clinical practice of psychiatrists and accident and emergency specialists in the United Kingdom concerning vitamin supplementation for chronic alcohol misusers. Alcohol Alcohol 1999;34:862-7. PMID 10659721
119: Hor ESL, Singh GP, Omar NA, Russell V. Atypical neuroleptic malignant syndrome and non-alcoholic Wernicke's encephalopathy. BMJ Case Rep 2021;14(8):e244082. PMID 34353834
120: Hoyumpa AM Jr, Nichols S, Henderson GI, Schenker S. Intestinal thiamin transport: effect of chronic ethanol administration in rats. Am J Clin Nutr 1978;31:938-45. PMID 149496
121: Hung SC, Hung SH, Tarng DC, et al. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2001;38:941-7. PMID 11684545
122: Ihara M, Ito T, Yanagihara C, Nishimura Y. Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature. Clin Neurol Neurosurg 1999;101:118-21. PMID 10467908
123: Imtiaz S, Muzaffar N. Ifosfamide neurotoxicity in a young female with a remarkable response to thiamine. J Pak Med Assoc 2010;60(10):867-9. PMID 21381624
124: Invernizzi F, Panteghini C, Chiapparini L, et al. Thiamine-responsive disease due to mutation of tpk1: importance of avoiding misdiagnosis. Neurology 2017;89(8):870-1. PMID 28747443
125: Ishibashi S, Yokota T, Shiojiri T, et al. Reversible acute axonal polyneuropathy associated with Wernicke-Korsakoff syndrome: impaired physiological nerve conduction due to thiamine deficiency. J Neurol Neurosurg Psychiatry 2003;74:674-6. PMID 12700319
126: Javaid S, Lindenberg A, Srinivasan R. Can the ketogenic diet lead to Wernicke's encephalopathy? J Pediatr Rehabil Med 2022;15(2):335-40. PMID 35147570
127: Jiang W, Gagliardi JP, Raj YP, et al. Acute psychotic disorder after gastric bypass surgery: differential diagnosis and treatment. Am J Psychiatry 2006;163:15-9. PMID 16390883
128: Johkura K, Naito M. Wernicke’s encephalopathy-like lesions in global cerebral hypoxia. J Clin Neurosci 2008;15:318-9. PMID 18178437
129: Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik SI. Neurologic complications of gastric bypass surgery for morbid obesity. Neurology 2007;68:1843-50. PMID 17515548
130: Kalidass B, Sunnathkal R, Rangashamanna DV, Paraswani R. Atypical Wernicke's encephalopathy showing involvement of substantia nigra. J Neuroimaging 2012;22(2):204-7. PMID 21121997
131: Kalmanchey R, Koos R, Majtenyi K, Borsi J. Wernicke-encephalopathy in children with cancer. Med Pediatr Oncol 1994;22:133-6. PMID 8259100
132: Karaiskos I, Katsarolis I, Stefanis L. Severe dysphagia as the presenting symptom of Wernicke-Korsakoff syndrome in a non-alcoholic man. Neurol Sci 2008;29:45-6. PMID 18379741
133: Karakonstantis S, Galani D, Korela D, Maragou S, Arna D, Basta M. Missing the early signs of thiamine deficiency. A case associated with a liquid-only diet. Nutr Neurosci 2020;23(5):384-6. PMID 30092713
134: Karapanayiotides T, Zaloni I, Thomaides T. Delayed development of Wernicke encephalopathy after gastrectomy. Arch Neurol 2006;63:1026. PMID 16831975
135: Kearsley JH, Musso AF. Hypothermia and coma in the Wernicke-Korsakoff syndrome. Med J Aust 1980;2:504-6. PMID 7207347
136: Kennedy R, Hunt S, Ahmad J, Menezes C, Clements WB, Kennedy JA. Wernicke's encephalopathy after laparoscopic cardiomyotomy for achalasia. JPEN J Parenter Enteral Nutr 2007;31:324-5. PMID 17595443
137: Kerns JC, Arundel C, Chawla LS. Thiamine deficiency in people with obesity. Adv Nutr 2015;6(2):147-53. PMID 25770253
138: Kinoshita Y, Inoue Y, Tsuru E, Yasukouchi H, Yokota A. Unusual MR findings of Wernicke encephalopathy with cortical involvement. No to Shinkei 2001;53:65-8. PMID 11211734
139: Kinsley S, Giovane RA, Daly S, Shulman D. Rare case of Marchiafava-Bignami disease due to thiamine deficiency and malnutrition. BMJ Case Reports 2020;13(12):e238187. PMID 33303506
140: Kirty K, Sarda Y, Jacob A, Venugopala D. Wernicke's encephalopathy post hyperemesis gravidarum misdiagnosed as Guillain-Barre syndrome: lessons for the frontline. BMJ Case Rep 2021;14(3):e239977. PMID 33727293
141: Kishimoto Y, Ikeda K, Murata K, Kawabe K, Hirayama T, Iwasaki Y. Rapid development of central pontine myelinolysis after recovery from Wernicke encephalopathy: a non-alcoholic case without hyponatremia. Intern Med 2012;51(12):1599-603. PMID 22728498
142: Koeppen AH, Daniels JC, Barron KD. Subnormal body temperatures in Wernicke's encephalopathy. Arch Neurol 1969;21:493-8. PMID 5344357
143: Koguchi K, Nakatsuji Y, Abe K, Sakoda S. Wernicke's encephalopathy after glucose infusion. Neurology 2004;62:512. PMID 14872047
144: Kohnke S, Meek CL. Don't seek, don't find: The diagnostic challenge of Wernicke's encephalopathy. Ann Clin Biochem 2021;58(1):38-46. PMID 32551830
145: Koike H, Iijima M, Mori K, et al. Postgastrectomy polyneuropathy with thiamine deficiency is identical to beriberi neuropathy. Nutrition 2004;20:961-6. PMID 15561484
146: Koike H, Iijima M, Sugiura M, et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 2003;54:19-29. PMID 12838517
147: Koike H, Ito S, Morozumi S, et al. Rapidly developing weakness mimicking Guilain-Barre syndrome in beriberi neuropathy: two case reports. Nutrition 2008;24:776-80. PMID 18440777
148: Koike H, Misu K, Hattori N, et al. Postgastrectomy polyneuropathy with thiamine deficiency. J Neurol Neurosurg Psychiatry 2001a;71:357-62. PMID 11511711
149: Koike H, Mori K, Misu K, et al. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001b;56:1727-32. PMID 11425941
150: Kopelman MD. The Korsakoff syndrome. Br J Psychiatry 1995;166:154-73. PMID 7728359
151: Kopelman MD, Thomson AD, Guerrini I, Marshall EJ. The Korsakoff syndrome: clinical aspects, psychology and treatment. Alcohol Alcohol 2009;44:148-54. PMID 19151162
152: Kramer J, Goodwin JA. Wernicke's encephalopathy: complication of intravenous hyperalimentation. JAMA 1977;238:2176-7. PMID 410958
153: Kril JJ. Neuropathology of thiamine deficiency disorders. Metab Brain Dis 1996;11:9-17. PMID 8815394
154: Kulkarni S, Lee AG, Holstein SA, Warner JE. You are what you eat. Surv Ophthalmol 2005;50:389-93. PMID 15967192
155: Kumar N. Acute and subacute encephalopathies: deficiency states (nutritional). Semin Neurol 2011;31(2):169-83. PMID 21590622
156: Kurtoglu S, Hatipoglu N, Keskin M, Kendirci M, Akcakus M. Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings. J Pediatr Endocrinol 2008;21:393-7. PMID 18556972
157: Kwee IL, Nakada T. Wernicke's encephalopathy induced by tolazamide. N Engl J Med 1983;309:599-600. PMID 6410237
158: Lallas M, Desai J. Wernicke encephalopathy in children and adolescents. World J Pediatr 2014;10(4):293-8. PMID 25515801
159: Landzberg DR, Bery E, Chico S, Koh S, Weissman B. Wernicke encephalopathy from olfactory dysfunction after COVID-19 infection. Neurologist 2021;26(6):274-5. PMID 34734907
160: Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J 2014;44(9):911-5. PMID 25201422
161: Lavin PJ, Smith D, Kori SH, Ellenberger C Jr. Wernicke's encephalopathy: a predictable complication of hyperemesis gravidarum. Obstet Gynecol 1983;62:13s-15s. PMID 6410313
162: Leigh D, McBurney A, McIlwain H. Wernicke-Korsakoff syndrome in monozygotic twins: a biochemical peculiarity. Br J Psychiatry 1981;139:156-9. PMID 7197998
163: Lian X, Wu M, Fan H, Zhang Y, Sun P. Wernicke's encephalopathy due to malnutrition and parenteral nutrition in a patient with cerebral infarction: a case report. Medicine 2020;99(16):e19799. PMID 32311995
164: Lindberg MC, Oyler RA. Wernicke's encephalopathy. Am Fam Physician 1990;41:1205-9. PMID 2181837
165: Lindboe CF, Loberg EM. Wernicke's encephalopathy in non-alcoholics: an autopsy study. J Neurol Sci 1989;90:125-9. PMID 2723677
166: Lipton JM, Payne H, Garza HR, Rosenberg RN. Thermolability in Wernicke's encephalopathy. Arch Neurol 1978;35:750-3. PMID 718474
167: Lockman PR, McAfee JH, Geldenhuys WJ, Allen DD. Cation transport specificity at the blood-brain barrier. Neurochem Res 2004;29:2245-50. PMID 15672546
168: Longmuir R, Lee AG, Rouleau J. Visual loss due to Wernicke syndrome following gastric bypass. Semin Ophthalmol 2007;22:13-9. PMID 17366112
169: Lonsdale D. Thiamin. Adv Food Nutr Res 2018;83:1-56. PMID 29477220
170: Lonsdale D. Wernicke's encephalopathy and hyperalimentation. JAMA 1978;239:1133. PMID 415154
171: Lopez RI, Collins GH. Wernicke's encephalopathy: a complication of chronic hemodialysis. Arch Neurol 1968;18:248-59. PMID 4868285
172: Lough ME. Wernicke's encephalopathy: expanding the diagnostic toolbox. Neuropsychol Rev 2012;22(2):181-94. PMID 22577001
173: Maeda M, Tsuchida C, Handa Y, Ishii Y. Fluid attenuated inversion recovery (FLAIR) imaging in acute Wernicke encephalopathy. Radiat Med 1995;13:311-3. PMID 8850375
174: Mair WG, Warrington EK, Weiskrantz L. Memory disorder in Korsakoff's psychosis: a neuropathological and neuropsychological investigation of two cases. Brain 1979;102:749-83. PMID 116710
175: Majolino I, Caponetto A, Scime R, et al. Wernicke-like encephalopathy after autologous bone marrow transplantation. Haematologica 1990;75:282-4. PMID 2227627
176: Makarewicz W, Kaska L, Kobiela J, et al. Wernicke's syndrome after sleeve gastrectomy. Obes Surg 2007;17:704-6. PMID 17658035
177: Mancinelli R, Ceccanti M, Guiducci MS, et al. Simultaneous liquid chromatographic assessment of thiamine, thiamine monophosphate and thiamine diphosphate in human erythrocytes: a study on alcoholics. J Chromatograph B Analyt Technol Biomed Life Sci 2003;789:355-63. PMID 12742126
178: Maney K, Pizoli C, Russ JB. Child neurology: infantile biotin thiamine responsive basal ganglia disease: case report and brief review. Neurology 2023;100(17):836-9. PMID 36657988
179: Manzanares W, Hardy G. Thiamine supplementation in the critically ill. Curr Opin Clin Nutr Metab Care 2011;14(6):610-7. PMID 21912244
180: Manzo L, Locatelli C, Candura SM, Costa LG. Nutrition and alcohol neurotoxicity. Neurotoxicology 1994;15:555-65. PMID 7854589
181: Mascalchi M, Simonelli P, Tessa C, et al. Do acute lesions of Wernicke's encephalopathy show contrast enhancement. Report of three cases and review of the literature. Neuroradiology 1999;41:249-54. PMID 10344508
182: McCool BA, Plonk SG, Martin PR, et al. Cloning of human transketolase cDNAs and comparison of the nucleotide sequence of the coding region in Wernicke-Korsakoff and non-Wernicke-Korsakoff individuals. J Biol Chem 1993;268:1397-1404. PMID 8419340
183: McEntee WJ. Wernicke's encephalopathy: an excitotoxicity hypothesis. Metab Brain Dis 1997;12:183-92. PMID 9346467
184: McEntee WJ, Mair RG, Langlais PJ. Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders. Neurology 1984;34:648-52. PMID 6200802
185: McLean J, Manchip S. Wernicke's encephalopathy induced by magnesium depletion. Lancet 1999;353:1768. PMID 10348000
186: Mellion M, Gilchrist JM, de la Monte S. Alcohol-related peripheral neuropathy: nutritional, toxic, or both. Muscle Nerve 2011;43(3):309-16. PMID 21321947
187: Mengi T, Beckmann Y. Wernicke encephalopathy with epileptic seizures during pregnancy. Neurocase 2022;28(2):185-7. PMID 35465832
188: Merkin-Zaborsky H, Ifergane G, Frisher S, et al. Thiamine-responsive acute neurological disorders in nonalcoholic patients. Eur Neurol 2001;45:34-7. PMID 11150838
189: Merola JF, Ghoroghchian PP, Samuels MA, Levy BD, Loscalzo J. Clinical problem-solving. At a loss. N Engl J Med 2012;367(1):67-72. PMID 22762321
190: Messina G, Quartarone E, Console G, et al. Wernicke's encephalopathy after allogeneic stem cell transplantation. Tumori 2007;93:207-9. PMID 17557572
191: Mifsud F, Messager D, Jannot AS, et al. Clinical diagnosis, outcomes and treatment of thiamine deficiency in a tertiary hospital. Clin Nutr 2022;41(1):33-9. PMID 34864453
192: Ming X, Wang MM, Zee D, Katz RM, Freeman JM. Wernicke's encephalopathy in a child with prolonged vomiting. J Child Neurol 1998;13:187-9. PMID 9568765
193: Mishra VV, Verneker RA. Hyperemesis gravidarum causing Wernicke-Korsakoff syndrome: a rare complication. J Obstet Gynaecol Res 2019;45(9):1929-31. PMID 31215137
194: Morrissey H, Ali F, John C, Pawar G, McQuade EA. Beriberi neuropathy mimicking Guillian-Barre syndrome in a teenager with food restriction: a case report. Cureus 2022;14(1):e21417. PMID 35198322
195: Mumford CJ. Papilloedema delaying diagnosis of Wernicke's encephalopathy in a comatose patient. Postgrad Med J 1989;65:371-3. PMID 2608577
196: Mungen E, Yaman Bajin I, Oz S, Gunbey C, Anlar B, Aydin B. Ifosfamide-induced encephalopathy with rapid response to thiamine: a pediatric case. J Pediatr Hematol Oncol 2022;44(7):402-4. PMID 35536996
197: Murata K, Yamaoka M, Ichikawa A. Reactivation mechanisms of thiamine with thermostable factors. J Nutr Sci Vitaminol (Tokyo) 1976;22(Suppl):7-12. PMID 978283
198: Murphy C, Bangash IH, Varma A. Dry beriberi mimicking the Guillain Barre syndrome. Pract Neurol 2009;9:221-4. PMID 19608771
199: Nadel AM, Burger PC. Wernicke encephalopathy following prolonged intravenous therapy. JAMA 1976;235:2403-5. PMID 817038
200: Nakamura H, Utsunomiya A, Ishida Y, Horita T. Thiamine deficiency in a nondrinker and secondary pulmonary edema after thiamine replenishment. Intern Med 2020;59(3):373-6. PMID 31534090
201: Nasrallah KM, Mitsias PD. Orthostatic tremor due to thiamine deficiency. Mov Disord 2007;22:440-1. PMID 17115381
202: Navarro D, Zwingmann C, Chatauret N, Butterworth RF. Glucose loading precipitates focal lactic acidosis in the vulnerable medial thalamus of thiamine-deficient rats. Metab Brain Dis 2008;23:115-22. PMID 18034292
203: Nazarov B, Jeannin S, Mejdoubi M, Signate A, Smadja D. Teaching neuroimages: bilateral anterior thalami and fornix macrohemorrhage in Wernicke-Korsakoff syndrome. Neurology 2011;77(22):e129. PMID 22123785
204: Nguyen JTT, Franconi C, Prentice A, Wycoco V. Wernicke encephalopathy hearing loss and palinacousis. Intern Med J 2019;49(4):536-9. PMID 30957373
205: Nightingale S, Bates D, Heath PD, Barron SL. Wernicke's encephalopathy in hyperemesis gravidarum. Postgrad Med J 1982;58:558-9. PMID 7145795
206: Nyce MQ, Chisholm JS, Szmanda JA, Boyce AK, Boczar CM, Kattah JC. Resolved external ophthalmoplegia and hearing loss in Wernicke's encephalopathy with thiamine replacement. J Neuroophthalmol 2021;41(4):e655-60. PMID 32833862
207: O'Brien NL, Quadri G, Lightley I, et al. SLC19A1 genetic variation leads to altered thiamine diphosphate transport: implications for the risk of developing Wernicke-Korsakoff's syndrome. Alcohol Alcohol 2022;57(5):581-8. PMID 35952336
208: Ogershok PR, Rahman A, Nestor S, Brick J. Wernicke encephalopathy in nonalcoholic patients. Am J Med Sci 2002;323:107-11. PMID 11863078
209: Ohkoshi N, Ishii A, Shoji S. Wernicke’s encephalopathy induced by hyperemesis gravidarum, associated with bilateral caudate lesions on computed tomography and magnetic resonance imaging. Eur Neurol 1994;34:177-80. PMID 8033946
210: Ohmori N, Tushima T, Sekine Y, et al. Gestational thyrotoxicosis with acute Wernicke encephalopathy: a case report. Endocr J 1999;46:787-93. PMID 10724354
211: Ohnishi A, Tsuji S, Igisu H, et al. Beriberi neuropathy: morphometric study of sural nerve. J Neurol Sci 1980;45:177-90. PMID 7365498
212: Oka M, Terae S, Kobayashi R, et al. Diffusion-weighted MR findings in a reversible case of acute Wernicke encephalopathy. Acta Neurol Scand 2001;104:178-81. PMID 11551240
213: Olsen RQ, Regis JT. Delirious deficiency. Lancet 2010;376(9749):1362. PMID 20951893
214: Onishi H, Kawanishi C, Onose M, et al. Successful treatment of Wernicke encephalopathy in terminally ill cancer patients: report of 3 cases and review of the literature. Support Care Cancer 2004;12:604-8. PMID 15141340
215: Oommen AT, Polavarapu K, Christopher R, Netravathi M. Biotin-responsive basal ganglia disease: treatable metabolic disorder with SLC19A3 mutation presenting as rapidly progressive dementia. Neurol India 2022;70(2):733-6. PMID 35532649
216: Opdenakker G, Gelin G, De Surgeloose D, Palmers Y. Wernicke encephalopathy: MR findings in two patients. Eur Radiol 1999;9:1620-4. PMID 10525877
217: Ortigoza-Escobar JD, Alfadhel M, Molero-Luis M, et al. Thiamine deficiency in childhood with attention to genetic causes: survival and outcome predictors. Ann Neurol 2017;82(3):317-30. PMID 28856750
218: Oudman E, Rensen Y, Kessels RPC. Confabulations in post-acute and chronic alcoholic Korsakoff's syndrome: a cross-sectional study conducted in two centres. Int J Psychiatry Clin Pract 2022;26(2):208-12. PMID 34057880
219: Oudman E, Wijnia JW, Oey M, van Dam M, Painter RC, Postma A. Wernicke's encephalopathy in hyperemesis gravidarum: a systematic review. Eur J Obstet Gynecol Reprod Biol 2019;236:84-93. PMID 30889425
220: Oudman E, Wijnia JW, Oey MJ, van Dam M, Postma A. Wernicke-Korsakoff syndrome despite no alcohol abuse: a summary of systematic reports. J Neurol Sci 2021;426:117482. PMID 34000679
221: Pagaling GT, Espiritu AI, Leochico CFD, et al. Wernicke-Korsakoff syndrome in hyperemesis gravidarum: a case report and literature review. Neurohospitalist 2021;11(2):141-7. PMID 33791058
222: Pawar RD, Balaji L, Grossestreuer AV, et al. Thiamine supplementation in patients with alcohol use disorder presenting with acute critical illness: a nationwide retrospective observational study. Ann Intern Med 2022;175(2):191-7. PMID 34871057
223: Pearce JM. Wernicke-Korsakoff encephalopathy. Eur Neurol 2008;59:101-4. PMID 17934284
224: Pentland B, Mawdsley C. Wernicke's encephalopathy following 'hunger strike'. Postgrad Med J 1982;58:427-8. PMID 7122386
225: Pereira DB, Pereira ML, Gasparetto EL. Nonalcoholic Wernicke encephalopathy with extensive cortical involvement: cortical laminar necrosis and hemorrhage demonstrated with susceptibility-weighted MR phase images. AJNR Am J Neuroradiol 2011;32(2):E37-8. PMID 21233235
226: Peters TE, Parvin M, Petersen C, Faircloth VC, Levine RL. A case report of Wernicke's encephalopathy in a pediatric patient with anorexia nervosa--restricting type. J Adolesc Health 2007;40:376-83. PMID 17367738
227: Pihko H, Saarinen U, Paetau A. Wernicke encephalopathy--a preventable cause of death: report of 2 children with malignant disease. Pediatr Neurol 1989;5:237-42. PMID 2679584
228: Polegato BF, Pereira AG, Azevedo PS, et al. Role of thiamin in health and disease. Nutr Clin Pract 2019;34(4):558-64. PMID 30644592
229: Popa I, Radulescu I, Dragoi AM, Trifu S, Cristea MB. Korsakoff syndrome: an overlook (Review). Exp Ther Med 2021;22(4):1132. PMID 34466144
230: Porta F, Siri B, Chiesa N, et al. SLC25A19 deficiency and bilateral striatal necrosis with polyneuropathy: a new case and review of the literature. J Pediatr Endocrinol Metab 2020;34(2):261-6. PMID 33544541
231: Pruckner N, Baumgartner J, Hinterbuchinger B, Glahn A, Vyssoki S, Vyssoki B. Thiamine substitution in alcohol use disorder: a narrative review of medical guidelines. Eur Addict Res 2019;25(3):103-10. PMID 30897571
232: Qureshi UA, Bhat AS, Qureshi U, et al. Infantile thiamine deficiency: Redefining the clinical patterns. Nutrition 2021;84:111097. PMID 33461052
233: Reuler JB, Girard DE, Cooney TG. Current concepts: Wernicke's encephalopathy. N Engl J Med 1985;312:1035-9. PMID 3885034
234: Rindi G, Imarisio L, Patrini C. Effects of acute and chronic ethanol administration on regional thiamin pyrophosphokinase activity of the rat brain. Biochem Pharmacol 1986;35:3903-8. PMID 3022743
235: Rindi G, Patrini C, Comincioli V, Reggiani C. Thiamine content and turnover rates of some rat nervous regions, using labeled thiamine as a tracer. Brain Res 1980;181:369-80. PMID 7350971
236: Roh JH, Kim JH, Koo Y, et al. Diverse MRI signal intensities with Wernicke encephalopathy. Neurology 2008;70:e48. PMID 18391151
237: Rugilo CA, Uribe Roca MC, Zurru MC, et al. Proton MR spectroscopy in Wernicke encephalopathy. AJNR Am J Neuroradiol 2003;24(5)952-5. PMID 12748100
238: Sanchez-Crespo NE, Parker M. Wernicke's encephalopathy: a tragic complication of gastric bypass. J Hosp Med 2006;1(suppl 2):72.
239: Sauberlich HE, Herman YF, Stevens CO, Herman RH. Thiamin requirement of the adult human. Am J Clin Nutr 1979;32:2237-48. PMID 495541
240: Scalzo SJ, Bowden SC, Ambrose ML, Whelan G, Cook MJ. Wernicke-Korsakoff syndrome not related to alcohol use: a systematic review. J Neurol Neurosurg Psych 2015;86(12):1362-8. PMID 25589780
241: Schabelman E, Kuo D. Glucose before thiamine for Wernicke encephalopathy: a literature review. J Emerg Med 2012;42(4):488-94. PMID 22104258
242: Schenker S, Henderson GI, Hoyumpa AM Jr, McCandless DW. Hepatic and Wernicke's encephalopathies: current concepts of pathogenesis. Am J Clin Nutr 1980;33:2719-26. PMID 6108071
243: Schroth G, Wichmann W, Valavanis A. Blood-brain-barrier disruption in acute Wernicke encephalopathy: MR findings. J Comput Assist Tomogr 1991;15:1059-61. PMID 1939760
244: Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007;6:442-55. PMID 17434099
245: Sechi G, Serra A, Pirastru MI, Sotgiu S, Rosati G. Wernicke's encephalopathy in a woman on slimming diet. Neurology 2002;58:1697-8. PMID 12058108
246: Sechi GP, Bosincu L, Cossu RP, et al. Hyperthermia, choreic dyskinesias and increased motor tone in Wernicke's encephalopathy. Eur J Neurol 1996;3(suppl 5):133.
247: Sedel F, Challe G, Mayer JM, et al. Thiamine responsive pyruvate dehydrogenase deficiency in an adult with peripheral neuropathy and optic neuropathy. J Neurol Neurosurg Psychiatry 2008;79:846-7. PMID 18559466
248: Sedhai YR, Shrestha DB, Budhathoki P, et al. Effect of thiamine supplementation in critically ill patients: A systematic review and meta-analysis. J Crit Care 2021;65:104-15. PMID 34118501
249: Seear M, Lockitch G, Jacobson B, Quigley G, MacNab A. Thiamine, riboflavin, and pyridoxine deficiencies in a population of critically ill children. J Pediatr 1992;121:533-8. PMID 1403385
250: Seehra H, MacDermott N, Lascelles RG, Taylor TV. Wernicke's encephalopathy after vertical banded gastroplasty for morbid obesity. BMJ 1996;312:434. PMID 8601118
251: Self M, Signorelli J, Lasoff D, et al. A Beriberi unhealthy latte: encephalopathy and shock from severe nutritional deficiency. J Emerg Med 2021;61(3):314-9. PMID 33836911
252: Shamir R. Thiamine-deficient infant formula: what happened and what have we learned. Ann Nutr Metab 2012;60(3)185-7. PMID 22699764
253: Shaw S, Gorkin BD, Lieber CS. Effects of chronic alcohol feeding on thiamin status: biochemical and neurological correlates. Am J Clin Nutr 1981;34:856-60. PMID 7234714
254: Shaw-Smith C, Flanagan SE, Patch AM, et al. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. Pediatr Diabetes 2012;13(4):314-21. PMID 22369132
255: Shepherd E, Smyth D, Sterenstein A, Dorsch A, Mizen T. Post-COVID Wernicke's presenting as bilateral vision loss. Am J Ophthalmol Case Rep 2022;25:101271. PMID 35075437
256: Shible AA, Ramadurai D, Gergen D, Reynolds PM. Dry beriberi due to thiamine deficiency associated with peripheral neuropathy and Wernicke's encephalopathy mimicking Guillain-Barre syndrome: a case report and review of the literature. Am J Case Rep 2019;20:330-4. PMID 30862772
257: Shikata E, Mizutani T, Kokubun Y, Takasu T. 'Iatrogenic' Wernicke's encephalopathy in Japan. Eur Neurol 2000;44:156-61. PMID 11053964
258: Shin NY, Man HS, Lee SK. Hemorrhagic Wernicke encephalopathy in a patient with liver transplantation. Neurology 2009;73:1423. PMID 19858466
259: Shin RK, Galetta SL, Imbesi SG. Wernicke encephalopathy. Arch Neurol 2000;57:405. PMID 10714669
260: Shogry ME, Curnes JT. Mamillary body enhancement on MR as the only sign of acute Wernicke encephalopathy. AJNR Am J Neuroradiol 1994;15(1):172-4. PMID 8141051
261: Shorey J, Bhardwaj N, Loscalzo J. Acute Wernicke's encephalopathy after intravenous infusion of high-dose nitroglycerin. Ann Intern Med 1984;101:500. PMID 6433765
262: Silva AR, Almeida-Xavier S, Lopes M, Soares-Fernandes JP, Sousa F, Varanda S. Is there a time window for MRI in Wernicke encephalopathy - a decade of experience from a tertiary hospital. Neurol Sci 2023;44(2):703-8. PMID 36335281
263: Simonik I, Bonaventura J, Tvaruzek J, Slamova M. Wernicke’s encephalopathy as rare complication after sleeve gastrectomy. Rozhl Chir 2019;98:66-70. PMID 30897914
264: Singh M, Thompson M, Sullivan N, Child G. Thiamine deficiency in dogs due to the feeding of sulphite preserved meat. Aust Vet J 2005;83:412-7. PMID 16035180
265: Singh S, Kumar A. Wernicke encephalopathy after obesity surgery. Neurology 2007;68:807-11. PMID 17353468
266: Sinha S, Kataria A, Kolla BP, Thusius N, Loukianova LL. Wernicke encephalopathy – clinical pearls. Mayo Clin Proc 2019;94(6):1065-72. PMID 31171116
267: Singleton CK, Martin PR. Molecular mechanisms of thiamine utilization. Curr Mol Med 2001;1:197-207. PMID 11899071
268: Smith H, McCoy M, Varughese K, Reinert JP. Thiamine dosing for the treatment of alcohol-induced Wernicke's encephalopathy: a review of the literature. J Pharm Technol 2021a;37(2):107-13. PMID 34752552
269: Smith TJ, Johnson CR, Koshy R, et al. Thiamine deficiency disorders: a clinical perspective. Ann N Y Acad Sci 2021b;1498(1):9-28. PMID 33305487
270: Smithline HA, Donnino M, Greenblatt DJ. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. BMC Clin Pharmacol 2012;12:4. PMID 22305197
271: Spinazzi M, Angelini C, Patrini C. Subacute sensory ataxia and optic neuropathy. Nat Rev Neurol 2010;6:288-93. PMID 20308997
272: Sriram K, Manzanares W, Joseph K. Thiamine in nutrition therapy. Nutr Clin Pract 2012;27(1):41-50. PMID 22223666
273: Stephens A, Patel K, Rao A, Browne P, Raley S, Street L. Recurrent Wernicke's encephalopathy in pregnancy: a case report. Nutr Neurosci 2019;22:528-30. PMID 29272216
274: Surges R, Beck S, Niesen WD, Weiller C, Rijntjes M. Sudden bilateral blindness in Wernicke's encephalopathy: case report and review of the literature. J Neurol Sci 2007;260:261-4. PMID 17512012
275: Suzuki S, Ichijo M, Fujii H, Matsuoka Y, Ogawa Y. Acute Wernicke's encephalopathy: comparison of magnetic resonance images and autopsy findings. Intern Med 1996;35:831-4. PMID 8933197
276: Tajima Y, Yoshida A, Ura S. Diffusion weighted MR imaging of Wernicke encephalopathy. No to Shinkei 2000;52:840-1. PMID 11064875
277: Tallaksen CM, Sande A, Bohmer T, Bell H, Karlsen J. Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally. Eur J Clin Pharmacol 1993;44:73-8. PMID 8436160
278: Talwar D, Davidson H, Cooney J, St JO’Reilly D. Vitamin B(1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay. Clin Chem 2000;46:704-10. PMID 10794754
279: Tan TX, Lim KC, Chan Chung C, Aung T. Starvation-induced diplopia and weakness: a case of beriberi and Wernicke's encephalopathy. BMJ Case Rep 2019;12(1). PMID 30610031
280: Tellez I, Terry RD. Fine structure of the early changes in the vestibular nuclei of the thiamine-deficient rat. Am J Pathol 1968;52:777-94. PMID 5651225
281: Thomson AD. Mechanisms of vitamin deficiency in chronic alcohol misusers and the development of the Wernicke-Korsakoff syndrome. Alcohol Alcohol Suppl 2000;35:2-7. PMID 11304071
282: Thomson AD, Cook CC, Touquet R, Henry JA, Royal College of Physicians, London. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and Emergency Department. Alcohol Alcohol 2002;37:513-21. PMID 12414541
283: Thomson AD, Marshall EJ. The natural history and pathophysiology of Wernicke's Encephalopathy and Korsakoff's Psychosis. Alcohol Alcohol 2006a;41:151-8. PMID 16384871
284: Thomson AD, Marshall EJ. The treatment of patients at risk of developing Wernicke's encephalopathy in the community. Alcohol Alcohol 2006b;41:159-67. PMID 16384870
285: Todd KG, Butterworth RF. Mechanisms of selective neuronal cell death due to thiamine deficiency. Ann N Y Acad Sci 1999;893:404-11. PMID 10672278
286: Todd KG, Hazell AS, Butterworth RF. Alcohol-thiamine interactions: an update on the pathogenesis of Wernicke encephalopathy. Addiction Biol 1999;4:261-72. PMID 20575793
287: Tomasulo PA, Kater RM, Iber FL. Impairment of thiamine absorption in alcoholism. Am J Clin Nutr 1968;21:1341-4. PMID 5699730
288: Torvik A, Lindboe CF, Rogde S. Brain lesions in alcoholics: a neuropathological study with clinical correlations. J Neurol Sci 1982;56:233-48. PMID 7175549
289: Toth C, Voll C, Macaulay R. Primary CNS lymphoma as a cause of Korsakoff syndrome. Surg Neurol 2002;57:41-5. PMID 11834275
290: Traviesa DC. Magnesium deficiency: a possible cause of thiamine refractoriness in Wernicke-Korsakoff encephalopathy. J Neurol Neurosurg Psychiatry 1974;37:959-62. PMID 4420329
291: Truedsson M, Ohlsson B, Sjoberg K. Wernicke’s encephalopathy presenting with severe dysphagia: a case report. Alcohol Alcohol 2002;37:295-6. PMID 12003921
292: Truong T, Hetzel F, Stiff KM, Husnain MG. Case of hypoactive delirium precipitated by thiamine deficiency. BMJ Case Rep 2021;14(3):e239886. PMID 33731408
293: Ueda Y, Utsunomiya H, Fujii A, Kanaumi T, Yasumoto S. Wernicke encephalopathy in a chronic peritoneal dialysis patient--correlation between diffusion MR and pathological findings. No To Hattatsu 2007;39:210-3. PMID 17515136
294: Unlu E, Cakir B, Asil T. MRI findings of Wernicke encephalopathy revisited due to hunger strike. Eur J Radiol 2006;57:43-53. PMID 16085381
295: Van Belle SJ, Distelmans W, Vandebroek J, et al. Phase I trial of erbulozole (R55104). Anticancer Res 1993;13:2389-91. PMID 8135472
296: Vasconcelos MM, Silva KP, Vidal G, et al. Early diagnosis of pediatric Wernicke's encephalopathy. Pediatr Neurol 1999;20:289-94. PMID 10328278
297: Victor M. MR in the diagnosis of Wernicke-Korsakoff syndrome. AJR Am J Roentgenol 1990;155:1315-6. PMID 2122686
298: Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome: a clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 1971;7:1-206. PMID 5162155
299: Vijayavel N, Koh SW, Goodman EL. Cystic fibrosis associated with Wernicke's encephalopathy in an older adult. BMJ Case Rep 2022;15(7):e249727. PMID 35896303
300: Vimokesant SL, Hilker DM, Nakornchai S, Rungruangsak K, Dhanamitta S. Effects of betel nut and fermented fish on the thiamin status of northeastern Thais. Am J Clin Nutr 1975;28:1458-63. PMID 803009
301: Wallis WE, Willoughby E, Baker P. Coma in the Wernicke-Korsakoff syndrome. Lancet 1978;2:400-1. PMID 79763
302: Wang S, Hou X, Ding S, et al. Refractory hypotension in a patient with Wernicke's encephalopathy. Alcohol Alcohol 2012;47(1):48-51. PMID 21969096
303: Watson AJ, Walker JF, Tomkin GH, Finn MM, Keogh JA. Acute Wernicke’s encephalopathy precipitated by glucose loading. Ir J Med Sci 1981;150:301-3. PMID 7319764
304: Weidauer S, Nichtweiss M, Lanfermann H, Zanella FE. Wernicke encephalopathy: MR findings and clinical presentation. Eur Radiol 2003;13:1001-9. PMID 12695821
305: Winslet MC, Donovon IA, Aitchison F. Wernicke's encephalopathy in association with complicated acute pancreatitis and morbid obesity. Br J Clin Pract 1990;44:771-3. PMID 2102239
306: Witt Ed, Goldman-Rakic PS. Intermittent thiamine deficiency in the rhesus monkey, I: progression of neurological signs and neuroanatomical lesions. Ann Neurol 1983;3:376-95. PMID 6838173
307: Woelk H, Lehrl S, Bitsch R, Kopcke W. Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I Study). Alcohol Alcohol 1998;33:631-8. PMID 9872352
308: Wohrle JC, Spengos K, Steinke W, Goebel HH, Hennerici M. Alcohol-related acute axonal polyneuropathy. Arch Neurol 1998;55:1329-34. PMID 9779661
309: Wood P, Murray A, Sinha B, Godley M, Goldsmith HJ. Wernicke's encephalopathy induced by hyperemesis gravidarum. Case reports. Br J Obstet Gynaecol 1983;90:583-6. PMID 6860605
310: Worden RW, Allen HM. Wernicke's encephalopathy after gastric bypass that masqueraded as acute psychosis: a case report. Curr Surg 2006;63:114-6. PMID 16520112
311: Yaguchi M, Yaguchi H, Nagaura C. [A case of Wernicke's encephalopathy with detrusor-sphincter dyssynergia]. Brain Nerve 2015;67(3):317-21. PMID 25846447
312: Yamashita M, Yamamoto T. Wernicke encephalopathy with symmetric pericentral involvement: MR findings. J Comput Assist Tomogr 1995;19:306-8. PMID 7890861
313: Yokote K, Miyagi K, Kuzuhara S, Yamanouchi H, Yamada H. Wernicke encephalopathy: follow-up study by CT and MR. J Comput Assist Tomogr 1991;15:835-8. PMID 1885806
314: Yoneoka Y, Takeda N, Inoue A, et al. Acute Korsakoff syndrome following mamillothalamic tract infarction. AJNR Am J Neuroradiol 2004;25:964-8. PMID 15205131
315: Yoon C, Gedzior J, DePry D. Wernicke-Korsakoff syndrome: focus on low-threshold diagnosis and prompt treatment in the primary care setting. Int J Psychiatry Med 2019;54:172-80. PMID 30823858
316: Zara G, Codemo V, Palmieri A, et al. Neurological complications in hyperemesis gravidarum. Neurol Sci 2012;33(1):133-5. PMID 21720901
317: Zhang SQ, Guan YT. Acute bilateral deafness as the first symptom of Wernicke encephalopathy. AJNR Am J Neuroradiol 2012;33(3):E44-5. PMID 22300936
318: Zhang Y, Culpepper K, Mathew R, CruzSaavedra L. Marchiafava-Bignami disease presenting as reversible coma. BMJ Case Rep 2022;15(4):e247852. PMID 35379680
319: Zhong C, Jin L, Fei G. MR imaging of nonalcoholic Wernicke encephalopathy: a follow-up study. AJNR Am J Neuroradiol 2005;26:2301-5. PMID 16219836
320: Zhu S, Qiang J, Xia Q, Wang Y, Zhang J, Liu X. Hypothalamic sydrome as an initial presentation of Wernicke encephalopathy: a case report. Medicine (Baltimore) 2019;98(26):e16181. PMID 31261554
321: Zuccoli G, Motti L. Atypical Wernicke’s encephalopathy showing lesions in the cranial nerve nuclei and cerebellum. J Neuroimaging 2008;18:194-7. PMID 18298680
322: Zuccoli G, Piptone N. Neuroimaging findings in acute Wernicke’s encephalopathy: review of the literature. AJR Am J Radiol 2009;192:501-8. PMID 19155417
323: Zuccoli G, Piptone N, Santa-Cruz D. Metronidazole-induced and Wernicke encephalopathy: two different entities sharing the same metabolic pathway. Am J Neuroradiol 2008;29:E84. PMID 18566011
324: Zuccoli G, Santa-Cruz D, Bertolini M, et al. MR imaging finding in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. Am J Neuroradiol 2009;30:171-6. PMID 18945789

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Neeraj Kumar MD

Dr. Kumar of the Mayo Clinic and the Mayo College of Medicine has no relevant financial relationships to disclose.
See Profile

Editor

Douglas J Lanska MD MS MSPH

Dr. Lanska of the University of Wisconsin School of Medicine and Public Health and the Medical College of Wisconsin has no relevant financial relationships to disclose.
See Profile

Patient Profile

Age range of presentation: 0 month to 65+ years
Sex preponderance: male=female
Heredity: Genetic defects underlie childhood-onset thiamine deficiency which are typically due to abnormalities in thiamine transport and metabolism.
Population groups selectively affected: alcoholics

critically ill patients

gastrointestinal surgery

malnutrition

malabsorption

parenteral nutrition
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-9: Korsakoff disease, psychosis or syndrome (alcoholic): 291.1

Korsakoff disease, psychosis or syndrome (nonalcoholic): 294.0

Nutritional polyneuritis: 357.4
ICD-10: Korsakoff syndrome, alcohol-induced or unspecified: F10.6

Polyneuropathy in nutritional deficiency: G63.4

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Thiamine deficiency

Associated Disorders

beriberi
Korsakoff psychosis
Korsakoff syndrome
Wernicke encephalopathy
Wernicke-Korsakoff syndrome

Differential Diagnosis

paramedian thalamic infarction
top-of-the-basilar syndrome
central nervous system lymphoma
Leigh disease
variant Creutzfeldt-Jakob disease
- paraneoplastic encephalitis
- ventriculoencephalitis
- Miller-Fisher syndrome
- severe hypophosphatemia
- alcoholic pellagra encephalopathy
- multiple sclerosis
- Behçet disease
- Whipple disease
- other CNS infections
- variety of acute and chronic intoxications (eg, metronidazole toxicity)
- cerebral hypoxia

Also Relevant

Alcohol abuse and its neurologic complications
Alpha-ketoglutarate dehydrogenase deficiency
Korsakoff syndrome
Memory loss
Nutrition and the brain
- Nutrition-related peripheral neuropathies
- Sudden unexplained nocturnal death syndrome

Clinical Categories

General Neurology

Patient Handouts

Web References

Clinical Trials

NIH: Nutritional Deficiency

Thiamine deficiency …

Thiamine deficiency

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Pathology

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Special considerations

Pregnancy

References

Contributors

Author

Editor

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Third nerve palsy

Nystagmus

Brain death/death by neurologic criteria

Hepatic encephalopathy

Cervical spondylotic myelopathy

Bowel dysfunction in neurologic disorders

Coma due to primary brainstem and diencephalic lesions

Transient visual loss

Thiamine deficiency

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Pathology

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Special considerations

Pregnancy

References

Contributors

Author

Editor

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Third nerve palsy

Nystagmus

Brain death/death by neurologic criteria

Hepatic encephalopathy

Cervical spondylotic myelopathy

Bowel dysfunction in neurologic disorders

Coma due to primary brainstem and diencephalic lesions

Transient visual loss

This is an article preview.
Start a Free Account
to access the full version.